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The objective of this thesis is to study, not only intellectual property strategies and how 
they can contribute to the likelihood of getting into a patent dispute, but also the tools 
and methods available to defend against possibly harmful third party patents. Europe, 
United States and China have been selected as countries to be studied as they comprise 
the most litigious regions. Inside Europe, again the most litigious countries have been 
selected for the study, that is, France, Germany and the United Kingdom.  
 
In the theoretical part of the study, the reader is introduced to the background of 
intellectual property, patents, patent disputes and management of the intellectual 
property. Intellectual property strategies are then described using a five level value 
hierarchy, including a defensive level, cost control level, profit center level, integrated 
level and visionary level. Each higher level in the pyramid represents the increasing 
demands placed upon the intellectual property function and each higher level also 
decreases the likelihood of getting into patent disputes. On the highest level, the 
company could, in theory, be relatively safe from any patent disputes from their 
competitors. But a new type of companies, called patent trolls, can still threaten 
companies who have mastered all five levels of the value hierarchy. 
 
Next, the defensive methods in Europe, United States and China are identified, together 
with the prerequisites for using them. It can be seen that even if the patent law is 
somewhat harmonized in Europe, each country can still interpret it differently. 
Furthermore, even if some of the methods are called the same in different countries, 
they can still have unique differences in when and how they are applied. Based on the 
comparison, advantages and disadvantages of each method’s applicability can be 
summarized. However, it should be noted that the use of any defensive method should 
be investigated case by case in order to determine its effect on the efficient resolution of 
a patent dispute. 
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Työn tavoitteena on tutkia, ei pelkästään immateriaalioikeusstrategioita ja kuinka ne 
voivat vaikuttaa todennäköisyyteen joutua patenttiriitoihin, vaan myös sitä, millaisia 
menetelmiä on käytettävissä puolustauduttaessa mahdollisesti vahingollisia kolmannen 
osapuolen patentteja vastaan. Eurooppa, Yhdysvallat ja Kiina on valittu 
tutkimuskohteiksi siitä syystä, että niissä käydään eniten patenttioikeudenkäyntejä. 
Euroopan sisältä on samasta syystä työhön valittu Ranska, Saksa ja Iso-Britannia. 
 
Teoriaosuudessa lukijalle esitellään immateriaalioikeuden, patenttien, patenttiriitojen ja 
immateriaalioikeuden hallinnan perusteita. Immateriaalioikeusstrategioita esitellään 
käyttäen viisitasoista arvohierarkiaa, sisältäen defensiivisen tason, kustannusseuranta 
tason, tuottavuuskeskeinen tason, integroidun tason, sekä edelläkävijä tason. Jokainen 
korkeampi taso pyramidissa edustaa lisääntyneitä vaatimuksia immateriaalioikeuden 
yksikölle ja jokainen korkeampi taso myös vähentää todennäköisyyttä joutua 
patenttiriitaan. Korkeimmalla tasolla yritys voi, ainakin teoriassa, olla suhteellisen 
turvassa kilpailijoiden aktivoimilta patenttiriidoilta. Uudentyyppiset yritykset, joita 
kutsutaan patenttipeikoiksi, voivat silti olla uhka yrityksille, jotka hallitsevat kaikki viisi 
tasoa arvohierarkiassa. 
   
Seuraavaksi identifioidaan defensiiviset menetelmät Euroopassa, Yhdysvalloissa ja 
Kiinassa, sekä perusedellytykset niiden käyttämiseen. Voidaan nähdä, että vaikka 
patenttilainsäädäntö onkin jokseenkin harmonisoitu Euroopassa, voi jokainen maa 
tulkita sitä eri tavoin. Tämän lisäksi, vaikka eräät esitetyt menetelmät ovat 
samannimisiä eri maissa, niissä voi silti olla suuria eroja sen suhteen, milloin ja miten 
niitä voi soveltaa. Kun eri menetelmiä verrataan keskenään, voidaan yhteenvetona 
esittää niiden käytettävyyden hyötyjä ja haittoja. On syytä kuitenkin huomioida, että 
jokaista defensiivistä menetelmää ja sen käyttökelpoisuutta patenttikiistojen 
tehokkaassa ratkaisemisessa, on syytä tutkia tapauskohtaisesti. 
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ABBREVIATIONS AND NOTATION 
  
Antitrust A defense argument to a patent infringement litigation. It 
is targeted against the plaintiff’s actions which violate the 
antitrust laws. 
Assertion An accusation of patent infringement in a form of a letter 
advising the infringer of the existence of a patent and 
asking the infringer to consider taking a license or stop 
the selling and production of the infringing product. 
BAI Board of Appeals and Interferences having responsibility 
over interference actions in the United States among other 
things.  
Claims Collection of single–sentence statements that define the 
scope of the patent owner’s rights. 
Compulsory license A nonconsensual patent license that a government 
compels a patent owner to grant to a third party. 
Declaratory judgement An accused infringer can initiate a legal action against a 
patentee, seeking a declaration from the court that the 
accused infringer does not infringe the patent is question. 
Defendant Person against whom an action or claim is brought in a 
court of law. 
Double patenting A prohibition against granting of more than one patent on 
a particular claimed invention in the same country. 
EPC European Patent Convention – A treaty allowing for the 
filing of a single patent application in order to obtain 
national patents in designated European countries, which 
have ratified the EPC. 
EPO European Patent Office – The central clearing house 
empowered to grant patents in all the countries that have 
signed the European Patent Convention. At grant, a single 
application results in a series of national patents. 
  vii
Equitable estoppel A defense argument to a patent infringement litigation. It 
is targeted against the plaintiff’s misleading actions. 
Filing The submission of the patent application to the patent 
office. The invention must be kept confidential before 
first filing to prevent invalidation on the grounds that it 
already existed in the prior art, except in countries having 
a grace period. 
FPC Federal Patent Court, is the first instance to take care of 
patent litigations in Germany. 
Grace period The inventor does not lose the rights for a patent if a 
patent application is filed within a specific period of time 
after making the invention public. 
Inequitable conduct A defense argument to a patent infringement litigation. It 
is targeted against the plaintiff’s improper acts in 
procuring a granted patent. 
Infringement The legal transgression that occurs when a third party 
utilizes the essential elements or characteristics of a patent 
invention. 
Injunction Equitable remedy, whereby a court can order a party to do 
or not do certain acts. I.e. to stop patent infringement. 
Interference Proceedings conducted in the USPTO to determine which 
of the two (or more) rival parties was the first to invent a 
particular claimed invention. 
Intervention A defence action allowing the accused infringer to 
intervene to open opposition proceedings after the 
opposition period has ended. 
Invalidate a patent  See Revoke a patent. 
IP Intellectual Property – intangible products of the human 
mind. 
IPR Intellectual Property Right – a legal right to exclude 
others from using or benefiting from persons creativity 
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and inventions. Defined rights protected by means of 
patents, trademarks, utility models, design registrations, 
and copyrights. 
ITC International Trade Commission is a federal agency in the 
United States responsible for example on adjudication of 
cases involving imports that allegedly infringe intellectual 
property rights. 
Laches A defense argument to a patent infringement litigation. It 
is targeted against the plaintiff’s unreasonable delay in 
filing a patent infringement action. 
License An agreement or covenant between a patentee and a 
licensee that the patentee will not sue the licensee for acts 
that would otherwise constitute infringement. 
Litigation   An act or process of bringing a lawsuit. 
Nonobviousness A criteria of patentability. Even if the invention is novel, 
it must represent enough of a qualitative advance over 
prior art (nonobviousness) in order to qualify for patent 
protection. 
Novelty A criteria of patentability. The invention must be new 
compared to prior art. 
Opposition The process by which a third party can attempt to 
challenge the validity of a granted patent in order to have 
it revoked or reduced in scope. 
Patent  A legal means of protecting a technical invention which 
confers a state monopoly lasting for up to 20 years. It 
must be applied to a genuinely novel product, process or 
apparatus which is also a truly inventive step forward. 
Patent office An official government office where patent applications 
are filed, prosecuted, opposed, appealed and granted. 
Most developed countries have their own national patent 
offices. 
  ix
Patentee Patent owner. A person, group or a company that has been 
granted a patent. 
Patent misuse A defense argument to a patent infringement litigation. It 
is targeted against the plaintiff’s behaviour in improperly 
expanding the scope of its rights. 
Person skilled in the art A hypothetical person from whose perspective the 
nonobviousness criteria is judged. 
Plaintiff   Person or company who brings an action in a court of law. 
Prior art Any form of communication in the public domain prior to 
first filing that refers to the technology embodied in an 
invention. The patent application will fail if the essential 
technology already exists in the prior art. 
Priority date The earliest date in which an individual patent application 
can depend on in order to circumvent prior art.  Anything 
published or disclosed after this date is not regarded as 
prior art. 
Prior use A defense argument to a patent infringement litigation. It 
is targeted to the prior actions of the accused infringer to 
allow the utilization of their product or process as they 
were before the patent in question was filed. 
Revocation action  Action to revoke a patent. 
Revoke a patent Granted patent is revoked if the grant is overruled. I.e. the 
rights relating to the patent are lost. 
Reexamination A defense method to resolve questions of patent validity 
via USPTO. 
Scope of protection The degree to which claims made in a patent can be 
extended to bring more potential products or processes 
into the range of the patent - thereby gaining additional 
commercial advantage. 
  x
SIPO The State Intellectual Property Organization (SIPO) in 
China having administrative control of patents and utility 
models. 
Third party observations An action where any third party can submit material to the 
patent office which they think could effect the allowing of 
the patent. 
USPTO United States Patent and Trademark Office (USPTO) 
managing the examination of patent applications and the 
granting of patents. 
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1. INTRODUCTION 
1.1. Background 
Patents are a form of legal protection for intellectual property. By protecting their 
invention by patent, the patent holder has a right to prevent unauthorized use of their 
invention. If a third party makes, sells or offers to sell an infringing product, they may 
be subject to penalties such as injunctions and damages. This right to recover economic 
damages from infringers is an important component of a system for intellectual property 
protection. (Mueller 2006, p. 5-8; Sepetys & Cox 2009, p. 1) 
The protection of intellectual property usually becomes more important when 
companies, nations or countries go through transition from manufacturing-based to 
knowledge-based production. In knowledge-based high technology industries, patent 
litigations are strategic actions used as means of improving competitive position in 
product and patent business. (Sepetys & Cox 2009, p. 1) 
Patent infringement litigations are becoming more and more popular around the world. 
Not surprisingly, USA has been the leader in the number of patent litigations for a long 
time. However, in 2005, China surpassed USA as the world’s most litigious country for 
patent infringement disputes (Bai et al 2007, p. 45). In 2005, intellectual property 
disputes filed with Chinese courts totaled 13 424, whereas only 10 905 cases were filed 
in the United States (Evalueserve, 2008). The amounts of damages awarded in China 
are also growing as can be seen in Table 1 (Sepetys & Cox 2009, p. 8), but they are still 
nowhere near the amounts awarded in USA.  
  Table 1. The highest damage award in China (in US Dollars) 
Year Highest damage awarded in China 
2004      50 000 USD 
2005  1 100 000 USD 
2006     210 226 USD 
2007 44 300 000 USD 
2008   2 780 000 USD 
 
 
The largest damage awarded in USA was 1.5 billion US Dollars by the Federal District 
Court in the Microsoft v. Alcatel-Lucent litigation. The damage award was later 
reversed by the Court of Appeals for the Federal Circuit, so it remains to be seen if the 
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award stands. But this clearly draws attention to the magnitude of economic impact of 
patent litigations. (Levko et al 2008, p. 1) 
1.2. Research objective 
Increasing number of patent disputes all over the world and their economic impact has 
made it necessary for the companies of today to understand the patent environment they 
operate in. The aim of this thesis is to study not only intellectual property strategies and 
how they can contribute to the likelihood of getting into a patent dispute, but also the 
tools and methods available to defend against these possibly harmful third party patents. 
The emphasis here is to offer guidelines for defensive methods to be used against 
European, United States and Chinese patents, so that companies can make decisions to 
act upon risk of litigation. This means that conventional and non-conventional counter-
strategies available for a defendant are identified and alternative methods are compared 
to each other. The research questions are: 
1. What role does the company’s intellectual property strategy play in relation 
to the likelihood of getting into a patent dispute? 
2. What are the defensive methods available to be used against a third party 
patent, and what are the prerequisites for their use? 
3. Compared to each other, what are the advantages and disadvantages of the 
defensive methods?  
1.3. Research scope and limitations 
The first research question can be answered by examining intellectual capital and the 
framework for generating and extracting value from it. Once the framework has been 
defined, it can be brought to the level of intellectual property and applied there. This 
brings the reader closer to the actual implementation of the intellectual property 
strategies available. Once the different strategies are presented, it can be discussed how 
they can effect the likelihood of getting into a patent dispute. 
The second research question can be tackled by identifying methods available 
specifically against European, United States and Chinese patents. Europe, United States 
and China have been selected as they comprise the most litigious regions. Different 
countries have different laws and methods which companies can utilize in order to 
protect against litigious companies and also the prerequisites can vary from country to 
country.  
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Literature relating to law usually bundles together methods available via court 
proceedings, whereas literature relating to intellectual property describes methods 
available via the national or regional patent offices. These methods have rarely been 
discussed together and comparison of the methods is even rarer. The third research 
question can be answered when the different methods are compared to each other and 
their advantages and disadvantages are identified. 
Some of the discussed methods available for European patents are handled in a 
centralized way (i.e. in European Patent Office), whereas some of the methods are 
available only at a national level and each jurisdiction can have its own distinct 
approach to handle them. In that respect, only France, Germany, and United Kingdom 
have been analyzed. These three countries are again the most litigious within Europe, 
mainly because they comprise a big market. France, Germany and United Kingdom 
have been selected for other reasons as well, as they represent both common law and 
civil law countries (to be discussed on chapter 3.3) and due to their single/dual track 
systems (to be discussed more on chapter 3.4.4) 
The emphasis of the research is on studying methods which can be used against the 
actual patent in question, but still some of the methods discussed can be used against the 
actions of the patentee. The currencies used in the studied cases are as follows: $ stands 
for United States dollar, £ stands for Great Britain pound and € stands for European 
Union euro. 
Methods which can arise from agreements and contracts with third parties, such as 
indemnifications received from suppliers and licensing contracts, are out of the scope of 
this study. Also the prime defense, a non-infringement argument, is not considered here, 
as it will depend on the patent and the accused infringing product or method. Same 
applies also to a design-around method, which will depend on the actual patent and 
accused product or method. Moreover, only literature written in English or Finnish has 
been analyzed, even though some of the used laws and rules defined in the studied 
countries have been originally written in other languages. 
1.4. Research approach and methodology 
It is essential to identify and explain the approach taken, as well as the methodology 
used in the research.Olkkonen (1994, p. 26) divides scientific research into positivism 
and hermeneutics. Positivism is also known as logical empirism as it emphasizes natural 
empirical facts and the utilization of logic (Turunen 1978, p. 21). According to 
Metsämuuronen (2005, p. 200) anything that is visible and can be identified concretely 
shall be taken as granted. So positivism tries to find out regularity, which defines reality 
abstractly (Turunen 1978, p. 49). Therefore a researcher is an objective observer and 
any other research conducted on the subject should result into identical conclusions 
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(Olkkonen 1994, p. 35). The main weakness in positivism research is that it easily 
ignores the qualitative side of the research subject (Turunen 1978, p. 52). 
The qualitative research is based on hermeneutics, where the approach is to emphasize 
deeper understanding of the studied subject (Olkkonen 1994, p. 33). In hermeneutics the 
research subject is examined using subjective reasoning, therefore the conclusions will 
be based on the reasoning of the researcher having an effect on the repeatability 
(Olkkonen 1994, p. 35). Positivism promotes research topics which can be easily 
structured whereas hermeneutics presents topics which are difficult to analyze and 
where there is no theory to back it up (Olkkonen 1994, p. 37). 
In the Finnish business economics Neilimo & Näsi (1980, p. 67) have divided the 
research methodology into four distinct approaches: conceptual, decision-oriented, 
nomothetical and action-oriented. Kasanen et al (1991, p. 257) have later supplemented 
the model with a fifth approach called the constructive approach. Figure 1 will present 
the five research approaches. 
 
Conceptual 
approach
Nomothetical 
approach 
Decision-
oriented 
a
Action-oriented 
app
 
 
Figure 1. Five research approaches (Kasanen et al., 1991) 
The approaches have been divided into two axes. The horizontal axis (Theoretical – 
Empirical) describes method used for gathering information. The vertical axis 
(Descriptive – Normative) presents the intention of the study. In descriptive study the 
intention is to describe an event by creating concepts, classifying and presenting 
correlations in order to understand it better. In normative study the intention is to find 
results which can be used as guidelines for developing or creating activities. (Olkkonen 
1994, p. 44) 
pproach
Constructive 
a
roach
Theoretical Empirical
Descriptive 
Normative 
pproach 
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The borders between the five approaches are not exclusive or particularly clear. The 
division into positivism and hermeneutics is not quite straightforward between the 
categories. However, positivism in its most pure form is presented in the nomothetical 
approach, whereas the characterestics of a hermeneutic study can be identified in the 
action-oriented approach. By nature, the decision-oriented approach can be categorized 
as positivism when theoretical reasoning is based on logical deduction. Conceptual 
approach can be classified as either positivism or hermeneutics depending on whether 
the purpose is to understand the event or to make conclusions based on empirical 
information. (Olkkonen 1994, pp. 60-80) 
The purpose of the conceptual approach is to produce conceptual systems. New systems 
are needed to describe and identify different types of event. The produced concepts can 
be entirely new or an improvement of an earlier concept. The used basis for conceptual 
approach is usually other concept systems, empirical information about the subject and 
relating theories. The method utilizes comparisons, analysis and synthesis. (Olkkonen 
1994, pp. 65-66) 
Decision-oriented approach aims to develop mainly methods based on mathematics, 
which can be utilized in decision making. The results are usually more or less 
mathematical or software models, which can be used to study the results of a decision or 
which gives a recommended decision. In this kind of research the model is usually 
created based on the known dependences of the variables. (Olkkonen 1994, p. 70) 
Nomothetical approach aims to find dependencies between variables in the empirical 
material. The purpose is to find which variables are influencing the change of the 
research subject. The results can be used to plan activities or to forecast events. 
(Olkkonen 1994, pp. 67-68) 
Action-oriented approach focuses on understanding the researched subject. It is typical 
that there are no neutral observations, which the researcher could measure. In fact, the 
researcher will base his/her interpretation on his/her own understanding of the subject 
matter. The research problem is usually more or less dynamic and it might be hard to 
divide it into smaller research sections. Material is empirical even though there is 
usually only a low number of events available for analysis. Verification of the results is 
challenging and on many occasions there simply is no verification for the conclusions. 
(Olkkonen 1994, pp. 72-74) 
Constructive approach aims to solve problems with the help of models and plans and to 
verify the results in practice by developing a proposed decision. Creativity and 
innovation are the basis for forming a conclusion in the constructive approach. The 
value of the results is that it will increase the general knowledge and improve the theory 
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regarding the tools for solving that particular type of problems. (Olkkonen 1994, pp. 75-
79) 
Business economics research is rarely exclusively under only one type of research 
approach (Olkkonen 1994, p. 80). It is typical that the first part of the study applies 
primarily conceptual approach and the rest utilizes the hermeneutics approach 
(Olkkonen 1994, pp. 80-81). Next, the research problems, which were presented in 
chapter 1.2, are used to determine the most efficient approach to be used. 
This research will utilize both positivism and hermeneutics viewpoints. First, the theory 
behind intellectual property, patents, patent disputes and intellectual property 
management will provide a starting point for this study. Literature survey forms the 
basis for the study and introduces the reader to the world of intellectual property. 
Different defensive methods will be identified based on verified facts, and they can be 
categorized based on their operation. This approach is relatively near to the conceptual 
approach. Next, the methods are studied further to clarify the differences between them 
and to use those results to identify their advantages and disadvantages.Empirical data 
available will also be taken into account. So the last research question will be answered 
by using both action-oriented and constructive approaches. The advantages and 
disadvantages are all subjective evaluations and it will be hard to verify the results for 
that reason. On the other hand the comparison will definitely increase the general 
knowledge on how patent disputes can be handled. This is true also when studying the 
intellectual property strategy in relation to patent disputes. The strategy is defined using 
conceptual approach and when different strategies are compared to each other, the 
conclusion on the effect on the likelihood of patent disputes can be drawn. Again, 
researchers own subjective view is used to understand the relationship between the 
intellectual property strategy and patent dispute likelihood. 
1.5. Research structure 
The structure of the study is presented in figure 2. The research questions are shown 
inside a circle and the theory behind them in rectangles. The arrows represent the 
logical reasonin on how the questions can be answered. 
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Figure 2. Structure of the study 
Chapter 2 will lead the reader to the background of intellectual property and how to 
manage it. It will also dive into the details of patents and patent disputes. Chapter 3 will 
then define the intellectual property strategies and the logical thinking performed is used 
to identify the relation to the likelihood of patent disputes. Chapter 3 will also present 
the patent systems in Europe, United States and China before going into the details of 
the defensive methods available in each country. Each defensive method, together with 
the prerequisites for their use, is introduced to the reader.  
Chapter 4 will compare the different methods to each other in order to find out their 
advantages and disadvantages. This is finally summarized into a table providing 
information about each defensive method, prerequisites for their use and the found 
advantages and disadvantages. The final chapter will also include the assessment of the 
study and recommendations for further study. 
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2. BACKGROUND ON INTELLECTUAL 
PROPERTY, PATENTS, AND PATENT DISPUTES 
2.1. Background on intellectual property 
The copying and reproduction of products has become much easier than it was 
previously. Therefore the laws created by many countries to protect inventions and 
creative work have become increasingly important to companies and individuals. The 
adopted patent laws give exclusive rights to the author, inventor or applicant but the 
rights are usually transferable. The main categories of intellectual property rights are 
presented in figure 3. Intellectual property protects also other rights such as trade 
secrets, know-how, domain names, appellations of origin, and indications of source. 
Intellectual properties owned by a company are often called intangible assets. (WIPO, 
2005; Oesch & Pihlajamaa, 2008) 
  
Intellectual Property
Industrial 
Property 
Copyright 
Patent Trademark  
Industrial 
Design
Utility 
Model
 
Figure 3. Intellectual Property 
Copyright protects the rights of an author, performer, producer and broadcaster. 
Copyright is gained by the initial creation of a work and does not necessitate any 
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registration of the right or publicity of the work. A wide range of creative work is 
covered by copyright, such as musical, artistic work, computer programs, photographic 
work, literary, technical drawings and motion pictures. The purpose of the copyright is 
to protect only the physical or otherwise detectable layout of the work or performance, 
not the idea or the message. The term of the copyright is usually bounded to the author’s 
lifetime. But typically the copyright is also effective for 50-70 years after the author’s 
death. (WIPO, 2005; Charmasson 2004, p. 13) 
Trademarks are distinctive signs, used to differentiate between identical or similar 
goods and services offered by different producers or services providers. The form of a 
trademark can vary widely. They can include, for example, letters, numbers, words, 
drawings, colors, sounds, fragrances, or any combination thereof. Trademarks can be 
established either on the basis of use or registration. (WIPO, 2005; Oesch & Pihlajamaa 
2008, p. 401) 
Industrial designs (also called design patents) protect ornamental or aesthetic aspects of 
products, they do not protect any technical aspects. The industrial design can consist of 
two- or three-dimensional features, such as shape, surface, patterns, and color. (WIPO, 
2005; Oesch & Pihlajamaa 2008, p. 390) 
Utility models, also known as “petty patents” are very similar to patents, but are a 
cheaper and quicker form of protection. They are usually applied to smaller inventions 
and the protection period is shorter than for a patent. This form of protection is available 
only in a few countries, e.g. in Finland, Germany and China. (WIPO, 2005; Oesch & 
Pihlajamaa 2008, p. 384) 
This Master’s Thesis concentrates specifically on patents and, therefore the background 
of patents is discussed in the next chapter. 
2.2. Background on patents 
The patent system was created to prevent inventions from being copied. It was thought 
that inventors possessed a natural right to their inventions and those rights must be 
recognized by law. In order to obtain a patent, an inventor has to file an application to a 
patent office, such as the National Board of Patents and Registration in Finland. The 
application must describe the invention in words in such detail that an expert in the field 
can understand it. The patent application must also include claims which define the 
scope of protection for the patent. (Fitzsimmons 2002, p. 6-7; Durham 2004, p. 1-14) 
An examiner at the patent office will examine the application since the patent 
application claims should pass three criteria before it can be granted. These criteria are 
novelty, nonobviousness and technical feasibility. When a blocking prior art is 
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discovered, it is informed to the applicant in interim decisions and the applicant can 
narrow the scope of the invention by amending the claims in such way that the criteria 
of novelty and nonobvious are fulfilled. (Oesch & Pihlajamaa, 2008) 
A patent may then be granted if the invention is considered to be new and nonobvious to 
a person skilled in the art. Each patent normally has a limited lifetime of 20 years, 
although this can be sometimes extended if granting of the patent is delayed for some 
reason. Once the patent is granted, it can be licensed or used in litigation. (Fitzsimmons 
2002, p. 6-7; Durham 2004, p. 1-14) 
With few exceptions, a granted patent can only be utilized in the specific country where 
it has been granted. In order to obtain a reasonable coverage for an invention companies 
often apply for a patent for the invention in multiple countries. The priority date is the 
day on which a first patent application (e.g., the parent of a patent family) was filed in a 
national patent office. Later, when the patent owner files similar patent applications in 
other countries, the first filed priority application can be claimed and the latter 
applications receive the same effective filing date (priority date) as the first application. 
The effective filing date (priority date) can be claimed only during a 12-month period 
after the first filing. So a single invention can often result in a bunch of patents and 
patent applications in various countries. Such a bunch is called a patent family as they 
all share the same priority date (Oesch & Pihlajamaa 2008, p. 43)  
A patent can also be applied for through some regional patent systems, one important of 
which is the system provided by the European Patent Convention (EPC). EPC allows 
patents to be centrally examined and granted in 39 European countries at the moment. 
National validation of a granted EPC patent is still needed in the individual designated 
states where the patent holder wants to have the invention protected. Patents obtained 
via EPC are called European patents and will be discussed more on chapter 3.2. 
(Charmasson 2004, p. 273-281; Oesch & Pihlajamaa 2008, p. 148-158) 
Another important patent system is the Patent Cooperation Treaty (PCT) which 
provides an almost worldwide unified procedure for filing patent applications. However 
the PCT application does not provide a grant of the patent, but merely an international 
search on patentability, which the contracting states can utilize in case a national patent 
is applied later. The main advantage of filing a PCT application is to delay the filing of 
national or regional patents. As usually the deadline for filing any national or regional 
patents is 12 months from the date of filing the first application, but with a PCT 
application that deadline can be as much as 31 months from the first filing date. (Oesch 
& Pihlajamaa 2008, p. 145-148) 
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2.3. Background on patent disputes 
An accusation of patent infringement can be in the form of a lawsuit or in the form of a 
letter advising the infringer of the existence of a patent and asking the infringer to 
consider taking a license or stop the selling and production of the infringing product. 
The latter is called a patent assertion and that can also be done before the patent is 
granted. In that case, the patent owner does not have the statutory right to ask the 
accused infringer to stop the selling and production of their products though. In the case 
of a patent infringement lawsuit, the patent in question must be granted and enforceable.  
(Grossman & Hoffman 2005, p. 21-26) 
By asserting a pending patent application against a possible infringer the patentee can, 
however, ask a royalty charge from the infringer or even intimidate with possible 
litigation action in the future once the patent is granted. Once a notice of a third party 
patent existence is delivered to a company, the potential infringer has a duty to exercise 
due care in determining whether they are infringing (Heyman 2005, p. 9). In some 
jurisdictions the assertion letter has even higher significance, as damages can be 
calculated from the date that the infringer became aware of the patent or patent 
application (Yang et all 2004, p. 60). 
2.4. Managing intellectual property 
Generally speaking, company assets can be used to create value and to extract value. 
But what are companies’ assets nowadays? A study performed by Dr. Margaret Blair 
(2001, p. 1) indicates a significant change between companies’ tangible and intangible 
assets. Her study showed that in 1978, only 17 % of a companies’ value was associated 
with their intangible assets, but in 1998 as much as 69 % of the same companies’ value 
was based on with the value of their intangible assets. Davis and Harrison (2001, p. 7) 
lists a couple of reasons for this development such as the rapid rise of the internet and 
the value of information. They also mentioned the growing awareness of intellectual 
property rights due to patent infringement proceedings taken place in the United States, 
but also due to counterfeit products which companies now need to battle with (Davis & 
Harrison 2001, p. 7).  
Intellectual capital (see figure 4) is often seen as a hidden value, including for example 
employees’ skills and knowledge, company’s processes, documents, and also 
intellectual property. So the value is created by the Human Capital and can be extracted 
via Intellectual Assets. (Sullivan, 2000; Davis & Harrison, 2001) 
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Figure 4. Intellectual Capital with its components (Adapted from Sullivan 2000, p. 18) 
It can be challenging to assess the value of intellectual capital, because it cannot always 
be measured by direct cash flow. Products with innovative features can bring extra 
profit to company, and that profit can be measured. New processes can reduce the 
manufacturing cost and that surplus can be also be quantitavely analysed. But some 
intellectual capital value is indirect, such as company image or using intellectual 
property to block competition. (Sullivan, 2000) 
Managing intellectual property is fundamental to extracting value from it. In this area, 
technology companies (i.e. companies selling physical innovative products) have an 
advantage over service companies (i.e. companies that provide services via human 
capital), that do not hold a portfolio of intellectual properties. Technology companies 
can develop decision processes, databases and work processes to successfully extract 
value from their intellectual properties. In doing so, the companies create a culture, 
structure and decision-making capabilities for systematically extracting value from their 
intangibles. (Sullivan, 2000) 
If a company lacks the foundation of an intellectual property management system, they 
usually do not extract the degree of value from their intellectual capital they would be 
capable of. Usually, when many companies want to extract new or extra value from 
their intellectual properties it means a shift in focus away from defensive use into a 
offensive use. In defensive use the company views that the main value of their patent 
portfolio is to protect the company’s innovations from competitive attack. The 
contrasting view, that is offensive use, regards the portfolio as a great source of 
corporate value for companies willing to exploit it. (Sullivan, 2000) 
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According to Sullivan (2000), the value extraction activities must meet two criteria in 
order to accomplish an effective way for extracting value from intellectual property. 
First, the activities must be aimed at improving the company’s competitive position and 
second, they must become part of a systematic set of decision processes supported with 
databases that collectively allow the company to manage its intellectual property assets. 
(Sullivan, 2000) 
In short term, the value can be extracted by reducing patent portfolio expenses and 
increasing patent portfolio income by selling patents or by improving licensing revenue 
income. Much of the expenses associated with patent portfolio come in the form of 
patent maintenance fees and taxes. It is not unusual that companies find that some of 
their patents are no longer useful and can therefore be eliminated. Companies that have 
out-licensed their patents usually receive far less in licensing revenue than they 
expected based on their licensing agreements. Auditing the licensing income usually 
increases the amount of income in short term, even to outweigh the cost of auditing. In 
mid-term, the value can be extracted by increasing the patent portfolio quality, 
increasing the use of the portfolio in business negotiations, and expanding licensing, 
joint venturing and strategic alliance activities. (Sullivan, 2000) 
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3. IP STRATEGIES AND DEFENSIVE METHODS   
3.1. Intellectual property strategies  
Patents are one form of intellectual property and they can be used both defensively and 
offensively to bring value for the company. By owning patents, a company can exclude 
others from using the protected intellectual asset. This can create indirect value to the 
company. When patents are used offensively, this can mean producing and selling 
protected products, licensing the rights of the patent to competitors or selling the 
patents. This can create direct value for the company. Offensive use of patents can also 
mean using them to reduce costs, for example by reducing the possibility that other 
companies would sue the patent owner in fear that they would make a counter-attack 
with their own patents. (Sullivan, 2000) 
Sometimes patents are even more valuable than cash. For instance, when a company 
needs access to a technology owned by their competitor, the patents owned by each 
company can be used as bargaining chips to establish licensing agreements. The image 
of a company can also rely on their innovation capabilities and the technology 
leadership can be measured by the size and quality of their patent portfolio. (Sullivan, 
2000) 
A company’s intellectual property strategy can be either defensive or offensive by 
nature. This will of course depend a lot on the company’s business strategy and the role 
intellectual property is expected to play in it. The company defines a vision which it 
intends to achieve, and the company strategy should outline how the company will 
achieve it. Once the vision and strategy have been set, the company can define how 
intellectual property will contribute either by creating value or by extracting it. The flow 
of thought for aligning the vision, strategy, and intellectual property is shown in figure 
5. (Sullivan, 2000) 
Davis and Harrison (2001) have developed a value hierarchy (Figure 6), identifying five 
levels of activity and use for companies’ intellectual property. Each level represents a 
different expectation that the company has about the contribution that its intellectual 
property function should make for supporting the company’s vision and strategy. Each 
higher level in the pyramid represents the increasing demands placed upon the 
intellectual property function. Few, if any, companies in the world have mastered all 
five levels and extracted the maximum value from their intellectual assets. Not every 
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company needs to do so, but every company has room for improvement. The different 
levels of the pyramid are discussed more in the following. (Davis & Harrison, 2001) 
 
 
Figure 5. Alignment of vision, strategy, and intellectual property (Adapted from Davis 
& Harrison 2001, p. 99) 
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Figure 6. The value hierarchy by Davis & Harrison (2001) 
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On the defensive level, the main purpose of the intellectual property owned by the 
company is to use it for protection. By creating a pile of patents, bigger than their 
competitors, the companies hope to keep out any litigious competitors, since they would 
be able to negotiate a cross-license rather than go to court. At this level, the company 
can also use the intellectual property assets to prevent competitors from using them. 
(Davis & Harrison, 2001) 
On the cost control level, the focus is on reducing the cost of filing and maintenance of 
the portfolio. More effort is put on to decision-making regarding the countries in which 
to file, patent portfolio pruning is conscientious and patent agent selection is done based 
on more intensive negotiations. (Davis & Harrison, 2001) 
On the profit center level, companies turn to more proactive strategies that can generate 
additional revenues. Hence, portfolio mining and patent enforcement become of interest 
to companies at this level. (Davis & Harrison, 2001) 
On the integrated level, intellectual property ceases to focus only exclusively on self-
centered activities and companies on this level have integrated their intellectual property 
activities with those of other functions and embedded them in the daily operations, 
procedures and strategies. On this level, intellectual property function will contribute to 
decisions made by executives in research and development, human resources, 
marketing, mergers and acquisitions, etc. (Davis & Harrison, 2001) 
On the final visionary level, the intellectual property function has become deeply 
ingrained into the various other functions in the company and takes on the challenge of 
identifying future trends in customer preferences as well as future trends in the industry. 
(Davis & Harrison, 2001)  
Moving from one level to the next in the value hierarchy requires discipline, 
organization and coordination. So how will each level protect a company from dealing 
with litigious companies? On each level, the protection will be based on the company’s 
own patent portfolio, but as the quality of the patent portfolio increases from level to 
level, it will also increasingly deter competitors from even starting a patent litigation 
against the company. On the final visionary level, the company should have very good 
knowledge about new technology needs and customer preferences, so that they would 
be, at least in theory, able to protect the needed innovations before their competitors. In 
an ideal world this would mean that the company would need to utilize only its own 
patented innovations and therefore there would not be any risk of patent litigation. 
From the litigation risk point of view each new level brings more security when dealing 
with litigations from competitors in the market, but what if it’s not a competitor who 
threatens with litigation? A new kind of formed company has recently been in the 
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headlines, companies whose main strategy is to gain patents and do business with them 
without any meaning of productization. These kinds of companies are often called 
patent sharks or patent trolls. When a patent troll approaches a company infringing its 
patents, the defending party cannot use its own patent portfolio for leverage in 
negotiations (Beyers, 2005). For this reason, it makes the patent trolls as threatening as 
the toughest competitor in the market. Therefore, the defensive methods identified in the 
next chapters are valuable guidelines for companies facing litigation, regardless of 
whether the plaintiff is a patent troll or a competitor. 
3.2. European patent 
The European Patent Convention (EPC) established a system for filing a single patent 
application to obtain national patents in countries designated in the patent application. 
The procedures of the EPC are under the control of the European Patent Office (EPO), 
which handles the patent prosecution. The EPC is a treaty open only to European 
countries and, according to EPO web page, the 36 countries which have ratified or 
acceded to the EPC at the moment are: 
Austria   Hungary   Poland 
Belgium   Iceland   Portugal 
Bulgaria   Ireland    Romania 
Croatia   Italy    San Marino 
Cyprus   Latvia    Slovak Republic 
Czech Republic  Liechtenstein   Slovenia 
Denmark   Lithuania   Spain 
Estonia   Luxembourg   Sweden 
Finland   Malta    Switzerland 
France   Monaco   Turkey 
Germany   Netherlands   United Kingdom 
Greece   Norway   Former Yugoslav, 
Republic of Macedonia  
 
The European patent can also be extended to countries which are not EPC contracting 
states, but which have however negotiated arrangements with the EPO enabling them to 
be designated in a European patent application. These three extension states, according 
to EPO web page, at the moment are: 
Albania Bosnia and Herzegovina     Serbia 
 
The patentable subject matter according to EPC Article 52 (Appendix 1) are any 
inventions, in all fields of technology, provided that they are new, involve an inventive 
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step and are susceptible of industrial application. However, the following are not 
regarded as inventions, and are therefore not patentable subject matter as such: 
• Discoveries, scientific theories and mathematical methods; 
• Aesthetic creations; 
• Schemes, rules and methods for performing mental acts, playing games  
or doing business, and programs for computers; 
• Presentations of information. 
• Inventions the commercial exploitation of which would be contrary to  
"ordre public" or morality; such exploitation shall not be deemed to be so 
contrary merely because it is prohibited by law or regulation in some or 
all of the Contracting States; 
• Plant or animal varieties or essentially biological processes for the  
production of plants or animals; this provision shall not apply to 
microbiological processes or the products thereof; 
• Methods for treatment of the human or animal body by surgery or  
therapy and diagnostic methods practiced on the human or animal body; 
this provision shall not apply to products, in particular substances or 
compositions, for use in any of these methods. 
(EPC, 2007) 
The novelty requirement, according to EPC Article 54 (Appendix 1), means that the 
invention must be new i.e. it does not form part of the state of the art (commonly 
referred to as prior art). The state of the art comprises everything made available to the 
public by means of written or oral description, by use, or in any other way, before the 
date of filing of the European patent application. The exception to this rule is other 
European patents. If another European patent was filed before the invention in question 
and might not even be published by the time of filing the patent in question, it is still 
considered as prior art to the later filed European patent, and should be taken into 
account when determining the novelty of the invention. (EPC, 2007; Chartered Institute 
of Patent Agents, 2007) 
Inventive step requirement, according to EPC Article 56 (Appendix 1), means that 
taking into account the state of art, the invention is not obvious to a person skilled in the 
art. The person skilled in the art is an imaginary person who is presumed to have access 
to the entire state of the art and possesses a common general knowledge. However, the 
person skilled in the art has no inventive ingenuity. Inventive step can not however be 
challenged using a non-public earlier filed European patent. Non-public earlier filed 
European patent can only be used for challenging novelty. The industrial application 
requirement means that the invention can be made or used in any kind of industry. 
(EPC, 2007; Chartered Institute of Patent Agents, 2007) 
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3.3. European patent infringement actions 
If a patent owner wants to start a patent litigation using a European Patent, they can 
initiate it in those coutries where they have validated the European Patent. If the patent 
owner would like to initiate litigation in multiple EPC countries, they must initiate 
parallel infringement actions in each selected country based on the same European 
patent and directed against the same alleged infringer. The infringement actions are 
handled by the national courts in the states where the infringing acts have taken place. 
This means that the infringement actions of a European patent is dealt with by national 
law. There are significant differences between various national court systems and the 
way the court handles patent cases. Therefore it is not uncommon to have different 
rulings on the same patent infringement action in different courts. (European Patent 
Office 2006, p. 1-2) 
One of the significant differences is between common law and civil law countries. 
United Kingdom and Ireland are common law countries, whereas the rest of the EPC 
countries are civil law countries. These two systems have differences of approach. 
Common law is by origin based on customary law. It gives high value to precedents 
which are typically binding on courts of equal or lower status. Statutes are taken as 
prescriptive, with little room for creative interpretation. In contrast, civil law tends to be 
based on broader principles, with less emphasis on precedents, even though precedents 
are by no means ignored. Often the judge in civil law country has more freedom to 
interpret the law, if such circumstances call for it. (Ladas & Parry web page; Chartered 
Institute of Patent Agents, 2007) 
Several factors play a role in the decision making about where to start a patent litigation 
using a European Patent; 1) where the accused infringer sells or manufactures the 
infringing products or services; 2) length of the proceedings; 3) cost issues; 4) single or 
dual track court system; etc. The most experienced patent courts are in France, 
Germany, The Netherlands and the UK. (Hoyng & Eijsvogels, 2007) 
Since the infringement procedure in each EPC country can be a bit different, only 
Germany, France and United Kingdom will be discussed hereafter in more detail, as 
they represent the differences between common/civil law systems. 
Germany 
Speedy procedures of infringement actions certainly constitute a big attraction to the 
German jurisdiction. In first instance proceedings, most decisions are rendered within 
one year from the filing date of the infringement suit. According to German national 
law, several acts can be seen as infringing a patented invention, such as manufacturing, 
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offering for sale, selling, using, or importing a product which is a subject of the patent. 
(Hoyng & Eijsvogels, 2007, Schuster, 2004) 
The patent infringement cases are first brought to one of the twelve District Courts in 
Germany. In principle, the plaintiff has the choice of which court they want to use. 
District Court of Mannheim is known for its particularly quick procedure and the 
Frankfurt District Court is known for its liberal approach to issuing preliminary 
injunctions. But the District Court of Düsseldorf holds centre stage in classical patent 
infringement matters having the greatest number of cases to be heard each year. 
Currently that number is over 400 new cases each year, which is about 50% of all 
German patent cases. The selected District Courts decide the cases with a panel of three 
judges and the decision can be appealed to the Court of Appeals within one month and 
from the Court of Appeals to the Supreme Court within one month. Figure 7 shows the 
German court system. (Hoyng & Eijsvogels, 2007, Schuster, 2004) 
 
Court of Appeals Supreme Court District Court 
 
Figure 7. German court system 
France 
According to French national law the following can constitute as infringing act: 
• Making, offering, marketing or using a product which is the subject matter of the 
patent, or importing or stocking a product for such purposes; 
• Using a process which is the subject matter of the patent or when the third party 
knows, or it is obvious in the circumstances, that the use of the process is 
prohibited without the consent of the owner of the patent, offering the process 
for use on French territory; 
• Offering, marketing or using the product directly obtained by a process which is 
the subject matter of the patent or importing or stocking for such purposes. 
(Hoyng & Eijsvogels, 2007) 
 
The infringement cases are first brought to one of the seven First Instance Courts. The 
judges deciding on the patent infringement do not have any technical background. But 
due to the vast majority of patent cases brought to Paris Courts an intellectual property 
chamber has been created. Judges in this chamber have developed a recognized 
experience in patent matters. An appeal from the decision rendered by the First Instance 
Court can be made within one month from the date of serving the decision to the Court 
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of Appeal and appeal of their decision can be made to the Supreme Court within two 
months from the date of serving the decision. Figure 8 shows the French court system. 
(Hoyng & Eijsvogels, 2007) 
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Figure 8. French court system 
United Kingdom 
According to United Kingdom national law, the making, disposing of, offering to 
dispose of, using, importing or keeping a product which is subject of the patent is an act 
of infringement. Also if the patented invention is a process, the using of the process, 
offering for use the process, or disposing, keeping or importing any products obtained 
directly by means of that process is also an act of infringement. (Hoyng & Eijsvogels, 
2007) 
It is good to remember that United Kingdom is not a single jurisdiction but three: 
England and Wales, Scotland and the Northern Ireland. The patent disputes can be 
brought to four courts which are the Patents Court, the Patents Country Court in 
London, the Court of Session in Edinburg and the High Court of Northern Ireland in 
Belfast. A decision of the Patent Courts or High Courts can be appealed to the Court of 
Appeals and the subsequent Court of Appeals decision can be appealed to the House of 
Lords. Figure 9 shows the United Kingdom court system.  (Hoyng & Eijsvogels, 2007) 
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Figure 9. United Kingdom court system 
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3.4. Defensive methods in Europe 
3.4.1. Opposition 
Opposition gives an opportunity to attack a European patent on a central basis with the 
objective of having it revoked or limited by amendment for all the countries to which it 
applies. (Chartered Institute of Patent Agents 2007, p. 25/6) 
The granted European patent can be opposed on the basis of one or more of the grounds, 
defined in EPC Article 100 (Appendix 2), which are 
(a) the subject-matter is not patentable based on the patentability rules defined in 
EPC Articles 52 to 57 (Appendix 1). 
(b) the European patent does not disclose the invention in a manner sufficiently 
clear and complete for it to be carried out by a person skilled in the art, as defined in 
EPC Article 83  
(c) the subject-matter of the European patent extends beyond the content of the 
application as filed, or, if the patent was granted on a divisional application or on a 
new application filed under Article 61 (Appendix 3), beyond the content of the 
earlier application as filed. (EPC, 2007; Guidelines for examination in the European 
patent office 2007, p. 343) 
An opposition must be filed with the EPO Opposition Division within 9 months from 
the grant of a European patent and it is not deemed to have been filed until the 
opposition fee has been paid. There are no restrictions on who can file an opposition, 
except that it can not be the patentee itself, and it can be also filed jointly by more than 
one person or company. An appeal of the opposition decision can be filed with the EPO 
Board of Appeal (EPO web page; Chartered Institute of Patent Agents 2007, p. 25/5-7) 
Opposition proceedings usually take three to five years to resolve and they cost 
approximately €80,000 – €120,000. A European patent and each corresponding national 
patent remain in force unless and until revoked or surrendered. Therefore, filing an 
opposition does not preclude the opponent from subsequently filing a revocation or 
nullity action against the resultant national patent in the national courts unless the 
national law excludes this option. (EPO web page; Chartered Institute of Patent Agents 
2007, p. 25/5-6; Nykänen, 2009) 
3.4.2. Intervention 
According to EPC Article 105 (Appendix 4), if an opposition period has expired but 
there is a pending opposition, any third party who proves that proceedings for 
infringement of the patent have been instituted against them can intervene in the 
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opposition. The grounds are then the same as for an opposition (see chapter 3.4.1). A 
notice of intervention must be filed within 3 months after the infringement proceedings 
were started. (EPC, 2007) 
3.4.3. Third party observations 
According to EPC Article 115 (Appendix 5), a method called Third Party Observations 
can be used to oppose a patent before it’s granted or during an open opposition. There 
are no restrictions on who the party can be, except that it can not be a party of the 
proceedings (examination, opposition or appeal). It can take as much as five year to get 
a result based on observations if the patent is in opposition, or as little as six months if 
the patent is in examination. The cost of filing an observation can be approximately 
between €1,000 and €12,000, even though there is no official fee for filing it. The 
observation must be filed in writing and must include a statement of the grounds on 
which they are based. The grounds can only be based on patentability rules as defined in 
Articles 52 to 57 (Appendix 1). (EPC, 2007; Chartered Institute of Patent Agents 2007, 
p. 4/30-31; Nykänen, 2009) 
The observations can be filed at any time following the publication of a European patent 
application before the patent is granted, or during opposition or an appeal before the 
final decision is made. The party filing the observation does not however become a 
party to the proceedings (examination, opposition or appeal) and there will be no 
correspondence between the party and the EPO regarding the validity of the 
observations made. There is no limitation on how many times observations can be filed. 
(EPC, 2007; Chartered Institute of Patent Agents 2007, p. 4/30-31) 
3.4.4. Patent revocation 
To obtain a revocation of a granted European patent in each designated country after the 
expiry of the opposition period, a revocation action must be filed separately in all of the 
designated states. Many issues such as procedural laws, judges and interpretation of 
claims can affect the outcome of the revocation action. For instance, the same European 
patent may be maintained as granted in Germany, amended in France and revoked in the 
United Kingdom. (European Patent Office 2006, p. 1-3) 
If a litigation case is brought against a company in Europe using an EP patent it is 
possible to challenge the validity of the patent by filing a revocation action. In some 
countries the revocation action is handled by the same court as the infringement action, 
but in some countries it is handled by a different court. One reason for this is the 
cultural differences regarding how the grant of a patent is viewed. In France and United 
Kingdom a patent represents a contract between society and the inventor, and anyone 
accused with patent infringement can challenge the validity of the patent. The German 
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view is more paternalistic. Patents are granted because the state has decided, in its 
wisdom, that good will flow from their grant. Challenging the states decision is not 
viewed favorably and therefore in Germany a patent being invalid is not in itself a 
defense to a claim of patent infringement and therefore the same court will not decide 
on both actions. The following table (Table 2) will show if the same court will handle 
revocation action (single track) or if a different court will decide on it (dual track) 
(Ladas& Parry web page; Clerix, 2009) 
Table 2. Single track and dual track countries (adapted from Clerix 2009, p. 18) 
Single track countries  Dual Track Countries 
Belgium Austria 
Cyprus  Bulgaria 
Denmark Czech Republic 
Estonia Germany 
Finland Hungary 
France Norway 
Greece Poland 
Iceland Portugal 
Ireland Romania 
Italy Slovak Republic 
Latvia  
Liechtenstein  
Lithuania  
Luxembourg  
Malta  
Monaco  
Netherlands  
Slovenia  
Spain  
Sweden  
Switzerland  
Turkey  
United Kingdom  
 
In dual track countries, the defendant can request the infringement court to stay the 
proceedings until the validity issue is decided by another court. The practice of staying 
the proceeding is handled differently in different countries and in different courts. The 
main principle applied by the court in Düsseldorf (but also by other courts in Germany) 
is that the proceedings are stayed if it is highly likely that the revocation action 
proceeding will be successful. The high likelihood of revoking a patent is assumed if 
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prior art information can be presented to show that it is novelty destroying and in 
addition has not been assessed in the examination proceedings when the patent was 
granted. If the prior art presented is used only against lack of inventive step it is most 
likely that the request for stay is not granted. (Bergermann & Verhauwen, 2008) 
The grounds for a revocation action, as defined in EPC Article 138 (Appendix 6) in the 
contracting states are the same as for opposition (see chapter 3.4.1) with a couple of 
extra options as well (EPC, 2007):  
d) the protection conferred by the European patent has been extended; or 
e) the proprietor of the European patent is not entitled under Article 60, paragraph 
1 (Appendix 7). 
Since the revocation procedure in each EPC country can be a bit different, only 
Germany, France and United Kingdom will be discussed here in more detail, as they 
represent the differences in common/civil law system and also the differences between 
single/dual track processes. 
Germany 
In Germany, the accused infringer can file a revocation action with the Federal Patent 
Court (FPC), if they wish to challenge the validity of the patent. However, it is not 
possible to file a revocation action with the FPC if there is a pending opposition action 
for the same patent. An appeal of the FPC decision can be filed with the Supreme Court. 
Duration of the revocation proceedings depend on the court and delays can be expected 
if additional extensions are requested by the parties or if the court needs to appoint an 
expert. But generally, the revocation action lasts about 12-18 months in the FPC and 24-
36 months in the Supreme Court. The cost of a revocation action can be approximately 
€45,000 – €110,000 in the Federal Patent Court. Figure 10 shows the German court 
system for revocation actions. (Blumenröder 2007, p. 2; Ladas & Parry web page; 
Bittner 2008, p. 5; Hoyng & Eijsvogels, 2007) 
 
Federal Patent 
Court 
Supreme Court
 
Figure 10. German court system for revocation actions 
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In principle, patentability is considered the same way as defined by EPC Articles 52-57 
(Appendix 1), but the contents of prior applications may be interpreted in a slightly 
different way by the German FPC. There have been repeated discussions regarding the 
differences in practice between EPO and the German practice. Whereas in many cases 
the EPO seems to take the position of ‘photographic novelty’ the German practice has 
established a broader view which could be designated as ‘extended novelty’. The 
German courts consider that the ‘photographic novelty’ is something that is explicitly 
disclosed in the prior art documents and is therefore a more limited viewpoint. On the 
contrary, the ‘extended novelty’ approach also asks what the average man skilled in the 
art would read from the prior art document with the help of his knowledge. This means 
that also something that has not been explicitly mentioned in the prior art document can 
be considered to be disclosed if it is self-evident for the average man skilled in the art, 
as long as it is not considered as an inventive step. (Hoyng & Eijsvogels, 2007) 
Novelty can be attacked in the German FPC by using non-public documents filed earlier 
than the patent in question either as a national application in Germany, as an European 
application, or as a Patent Cooperation Treaty (PCT) application designating Germany 
as a country for protection. German FPC has also taken a bit more strict approach than 
the EPO for defining an inventive step. It occurs frequently that the FPC finds an 
invention to be lacking the inventive step even if the EPO has – in opposition 
proceedings – upheld the patent with the same prior art. (Hoyng & Eijsvogels, 2007) 
France 
In France, the accused infringer can file a revocation action to the same court where the 
infringement action is handled and they are heard together. Validity of the patent can be 
challenged based on the EPC patentability criteria as disclosed in chapter 3.2, as the 
French national law is very similar to the law under EPC. An appeal of the validity 
decision follows the same rule as for appeal for infringement, described in chapter 3.3 
figure 8. Duration of the proceedings including infringement and/or validity of the 
patent takes usually 16-25 months in the First Instance, 15-24 months in the Court of 
Appeal and 24 months in the Supreme Court, but delays can be expected if additional 
extensions are requested by the parties. The cost of infringement and/or validity 
proceedings is approximately €80,000 – €200,000 in the First Instance. (Hoyng & 
Eijsvogels, 2007) 
United Kingdom 
Validity of a patent can be challenged in the same court which handles the infringement 
action and is therefore a legitimate defense for infringement accusations. The revocation 
action can be filed even if there are no infringement actions ongoing. The approaches 
adopted by the United Kingdom courts for evaluating the grounds for revocation 
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(patentability, novelty and in particular inventive step) are not identical to those adopted 
by the EPO. As a common law jurisdiction, the precedents play an important role when 
courts assess these issues. (Hoyng & Eijsvogels, 2007) 
The leading precedent on novelty based on prior publication remains General Tire & 
Rubber Co. v. Firestone Tyre & Rubber Co. Ltd. The key ruling in that case was that if 
prior publication contains a clear description or instruction to do or make something that 
would infringe the patentee’s claim if carried out after the grant of the patentee’s patent, 
the patentee’s claim will have been shown to lack the necessary novelty. Another lack 
of novelty argument is if it can be shown that inevitable results of carrying out 
directions in the prior publication will result in something within the claim. (Hoyng & 
Eijsvogels, 2007) 
On inventive step, the UK does not adopt the EPO’s typical approach. The approach for 
analyzing inventive step is to follow the four steps laid down in a precedent of 
Windsurfing International v. Tabur Marine Ltd. The four steps by Hoyng & Eijsvogels 
(2007) are: 
1. Identify the inventive concept in the patent. 
2. Assume the mantle of the normally skilled but unimaginative skilled man of 
art at the priority date and impute to him what was, at that date, common 
general knowledge in the art. 
3. Identify what, if any, differences exist between the matter being cited as 
“known or used” (i.e. the prior art) and the alleged invention. 
4. The court must then ask whether those differences, absent any knowledge of 
the alleged invention, constitute steps which would have been obvious to the 
man skilled in the art, or whether they require any degree of invention. 
An important factor in each case is assessing who is the man skilled in the art and what 
the “common general knowledge” was of that person at thetime of the invention. This is 
assessed in a different and perhaps more exhaustive manner than in the EPO, primary 
evidence being provided by party-appointed experts in Court, who are typically cross-
examined. An appeal process follows the same route as the appeal for infringement 
presented in chapter 3.3, figure 9. Duration of the proceedings including infringement 
and/or invalidity of the patent takes usually 9-14 months in the First Instance and 12-18 
months in the Court of Appeal, but delays can be expected if additional extensions are 
requested by the parties. The cost of infringement and/or validity proceedings is 
approximately £350,000 – £1,000,000 in the Patents Court, the Patents Country Court, 
the Court of Session and the High Court. (Hoyng & Eijsvogels, 2007) 
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3.4.5. Compulsory licenses 
The compulsory license issue needs to be brought separately in each jurisdiction, as a 
defense argument. And again different jurisdictions can have different practices, 
therefore only Germany, France and United Kingdom will be discussed here in more 
detail. As the compulsory license defense will be heard by the same court where the 
revocation action is handled, the cost and duration of the proceedings are approximately 
the same. 
Germany 
A compulsory license can only be granted if the following conditions are fulfilled. The 
applicant has tried to obtain a license from the patentee and such efforts have lasted a 
reasonable time. The request also has to be made for reasonable conditions which are 
non-discriminatory. Only in a case where these efforts have been without success may a 
compulsory license be considered. (Hoyng & Eijsvogels, 2007) 
The compulsory license can also be requested in situations where a later filed patented 
invention (owned by the compulsory license requestor) comprises an important 
technical progress of considerable economic significance than another earlier filed 
patented invention and the exploitation of the later filed invention is dependent on the 
exploitation of the earlier filed invention. In that case, the court may grant a compulsory 
license to exploit the earlier filed invention. (Hoyng & Eijsvogels, 2007) 
If the compulsory license is granted, the licensee is obligated to pay the patentee 
reasonable royalties. Furthermore it has to be limited to the extent necessary. In 
Germany, the motion for granting a compulsory license has to be brought before the 
Federal Patent Court in the first instance. The decision can then be appealed before the 
Federal Supreme Court. In practice, there have been only a limited number of 
compulsory licenses requested, mainly from the pharmaceutical industry and the last 
case dates back to 1995. (Hoyng & Eijsvogels, 2007) 
France 
According to French national law, there are three different kinds of compulsory licenses 
granted: 
• Compulsory license for non-exploitation 
• Ex-officio license 
• Dependency license 
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If, within a certain time period, the patent owner has not started to exploit or has not 
made any preparations to start the exploitation of the invention, or has not marketed the 
patented product enough to satisfy the market, or has abandoned the work of the 
patented invention for more than three years, a compulsory license for non-exploitation 
can be obtained if the applicant can also show that they have tried to obtain a license 
from the patent owner, but failed. (Hoyng & Eijsvogels, 2007) 
Ex-officio licenses are granted if public bodies (public health, economic development or 
national defense) need it. Ex-officio licenses can be granted only by the Minister 
responsible for industrial property. (Hoyng & Eijsvogels, 2007) 
The dependency license can be granted if a later filed patent can not be exploited 
without infringing an earlier filed patent. The later filed patent must also then have 
substantial technical progress and it must constitute an economic interest regarding the 
prior art. (Hoyng & Eijsvogels, 2007) 
United Kingdom 
Compulsory licenses can only be sought if more than three years have passed after the 
grant of the patent. Based on who the patent owner is (WTO or non-WTO patent 
owner), different grounds for allowing the license are considered. A WTO patent owner 
is a national of or is domiciled in one of the WTO member countries or the patent owner 
has a real and effective industrial or commercial establishment in a WTO member 
country. Grounds for allowing a compulsory license for a patent owned by a WTO 
member are the following: 
• Demand of the patented product is not being met on reasonable terms. 
• The patent owner has refused to license the invention on reasonable terms 
when exploitation of a later filed invention is dependent on the exploitation 
of the earlier filed invention and the product in question has important 
technical advantages. 
• The patent owner has refused to license the invention on reasonable terms 
and for that reason the establishment or development of commercial or 
industrial activities in UK is unfairly prejudiced. 
(Hoyng & Eijsvogels, 2007) 
 
In any situation, the compulsory license requestor is first forced to seek license from the 
patent owner and if unsuccessful after a reasonable time period, the compulsory license 
request can be made. Furthermore, the national law also specifically excludes semi-
conductor technology from the scope of compulsory licenses. Grounds for allowing a 
compulsory license for a patent owned by a non-WTO member are the following: 
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• Patented invention is not being commercially worked, or to the fullest extent 
reasonably practicable, in the UK and the demand is not being met by 
importation. 
• Demand of the patented product is not being met on reasonable terms, or not 
being met via importation on a substantial extent.  
• Commercially workable patented invention is being prevented or hindered 
from being worked in the UK. 
• The patent owner has refused to license the invention on reasonable terms 
and therefore the export market from the UK is not being supplied. 
• The patent owner has refused to license the invention on reasonable terms 
and it is preventing an exploitation of another invention which makes a 
substantial contribution to the art. 
• The patent owner has refused to license the invention on reasonable terms 
and establishment or development of commercial activities in the UK is 
therefore prevented or hindered. 
• Situations where products or processes not covered by the patent have been 
unfairly prejudiced by the patent owner. 
(Hoyng & Eijsvogels, 2007) 
 
The application for compulsory license is made to the United Kingdom Patent Office 
and an appeal may be filed with the Patents Court. (Hoyng & Eijsvogels, 2007) 
3.4.6. Patent exhaustion 
The European Court of Justice has adopted a “community-wide exhaustion” approach 
comprising the entire European Union. This means that in some situations the patentee 
might lose his rights for opposing the free circulation of goods that infringe his patent, 
because he has used up or exhausted his patent rights due to expressed consent or 
implied consent. In principle, patent rights can be exhausted in the European Union if a 
specific product has been put on the market within the territory of patent protection 
either by the patentee or by a third party with the patentee’s consent. As a result, the 
patentee can not exercise his patent rights against third parties who use or sell or import 
to another EU country that specific product. The European Court of Justice has also 
ruled that putting the product on the market within European Union constitutes 
exhaustion irrespective of whether there is patent protection in the country where the 
product was put on the market the first place. As the patent exhaustion defense will be 
heard by the same court where the revocation action is handled, the cost and duration of 
the proceedings are approximately the same.  (Mueller 2006, p. 440; Hoyng & 
Eijsvogels, 2007) 
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3.4.7. Prior use 
The prior use defense needs to be brought separately in each jurisdiction, as a defense 
argument. Again, different jurisdictions can have different practices, but in Germany 
and United Kingdom the practices are much the same and therefore they are discussed 
here together, whereas France is described separately. As the prior use defense will be 
heard by the same court where the revocation action is handled, the cost and duration of 
the proceedings are approximately the same. 
Germany and United Kingdom 
A person who has before the priority date of a patent either done an act in good faith 
which would constitute an infringement of the patent or has made serious and effective 
preparations to do such an act has the right to continue to exploit the invention. But the 
acts and preparations must have happened in the country in question. An act done in 
good faith will exclude for example acts carried out in breach of confidence or some 
other bad faith manners. In the United Kingdom, the serious and effective preparations 
need to be (according to precedents) at a very advanced stage, so that infringement is 
about to occur. The rights achieved this way are usually relatively narrow, protecting 
only the substance as it was on the day of priority in the UK. In Germany the serious 
and effective preparations are defined as having an intention to use the invention and 
that necessary arrangements for a use have been made. The rights achieved this way in 
Germany, include also variants of the product as long as they do not interfere with the 
subject of the patented invention. (Hoyng & Eijsvogels, 2007) 
France 
Any person, who within the territory possessed in good faith the invention before the 
priority date of the patent, shall enjoy personal right to work out the invention. The 
possession means that the prior invention must contain all the features claimed by the 
patent, even though full identity is not required, a simple equivalence between both is 
sufficient.  French conception of prior use is very specific. Contrary to many countries, 
in France, the personal right is broadly recognized: the prior user does not have to prove 
acts intended to work out the invention as is the case in Germany and United Kingdom. 
(Hoyng & Eijsvogels, 2007) 
3.4.8. Declaration of non-infringement 
Declaration of non-infringement has not been specifically provided by the European 
Patent Convention, however, such a declaration is available in some jurisdictions under 
national law (Chartered Institute of Patent Agents, 2007). In the United Kingdom, the 
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1977 Patents Act, chapter 37, Section 71 (Appendix 8) allows a court to grant a 
declaration of non-infringement of a patent if it is shown that  
a) the applicant has applied in writing to the proprietor for a written 
acknowledgement for a declaration of non-infringement and has furnished full 
particulars in writing of the act in questions, and 
 b) the proprietor has refused to give such acknowledgement. 
An application for a declaration of non-infringement relates to the product or process 
for which the declaration is sought, and no other. This means that if the patentee later 
observes any new products in the market and considers those to infringe its patent the 
patentee would have a possibility to raise new separate proceedings. (Chartered Institute 
of Patent Agents, 2007; United Kingdom Patent Act) 
It is not possible to seek a declaration of non-infringement in Germany, but in France it 
has been possible since 1984. The grounds for applying it are basically the same as in 
the United Kingdom. This defensive action can delay the infringement proceedings, 
therefore allowing more time for the defendant to come up with any other defensive 
methods usable in the infringement proceedings. As the declaration of non-infringement 
will be heard by the same court where the revocation action is handled, the cost and 
duration of the proceedings are approximately the same. (Chartered Institute of Patent 
Agents, 2007) 
The Brussels Convention of 1968 has made it possible to litigate patent infringement in 
a member state of the European Union even if the patent has been registered in another 
member state. If such patent infringement litigation is ongoing for example in Germany 
and a declaration of non-infringement action is started for example in the United 
Kingdom or France, the action may very well delay the patent enforcement in Germany. 
Thus, it can be a quite good defensive attack to select a country having a particularly 
slow judicial system. Italy is one example of such a slow judicial system and therefore a 
declaration of non-infringement action filed in Italy is sometimes also called as an 
‘Italian torpedo’, reflecting how it can jeopardize the infringement proceedings taking 
place in another member state. (Chartered Institute of Patent Agents, 2007; Brussels 
Convention, 1968) 
3.5. United States patents 
The United States Patent and Trademark Office (USPTO) is the administrative agency 
of the United States Government managing the examination of patent application and 
granting patents. According to Section 101 of title 35 of the United States Code 
(Appendix 9), the patentable subject matter is defined as follows:  
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Whoever invents or discovers any new and useful process, 
machine, manufacture, or composition of matter, or any new 
and useful improvement thereof, may obtain a patent therefor, 
subject to the conditions and requirements of this title. 
Thus basically everything under the sun that is made by man is, in theory, patentable in 
the United States. But first, the United States Constitution limits the power of Congress 
to the promotion of the “useful arts”, which are generally understood to include 
technological endeavors rather than, for example, artistic or social endeavors. 
Furthermore, section 101 also defines that the invention must fall within one of the 
statutory categories of process, machine, manufacture or composition of matter. But 
since the terms are still quite broad, many precedents have limited the patentability 
criteria more. So in practice, the law of nature, natural phenomena, abstract ideas, 
thinking processes, intelligent concepts, products found from nature, and publications 
are not regarded as patentable subject matter. (Greenlief, 2008; Durham 2004, pp. 23-
29) 
United States Code Section 102 of title 35 (Appendix 10) defines that a patent can be 
granted unless 
(a) the invention was known or used by others in the U.S. or was patented 
before or described in a publication anywhere in the world, before the 
invention was made, or 
(b) more than one year prior, the invention was patented or described in a 
publication anywhere in the world or in public use or sale in  the U.S., or 
(c) the inventor has abandoned the invention, or 
(d) the inventor has applied a patent outside of the U.S. more than 12 months 
before applying for it in the U.S., or 
(e) the invention was described in someone else’s published U.S. patent 
application (or in a PCT application where the U.S. was designated and the 
publication language was English) filed before the invention was made, or 
(f) the applicant himself did not invent the invention, or 
(g) another inventor invented the same invention before and has not abandoned 
the invention. 
Other requirements of patentability are novelty (United States Code, Section 102 of title 
35) and nonobviousness (United States Code, Section 103 of title 35), which are 
analyzed quite differently in United States than in other countries. This is due to the 
unique “first to invent” system. The “first to invent” system differs from the “first-to-
file” systems under which the rest of the world operates. The first to invent principle is 
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defined in United States Code, Section 102(g) of title 35 (Appendix 11). In theory this 
means that if two or more applicants apply for a U.S patent on the same invention, each 
having independently made the invention, the patent will be awarded to the one who 
was first in time to invent, regardless of the order in which the respective patent 
applications were filed. This does not however happen automatically, but the competing 
applicant must participate in an interference proceeding within the USPTO to determine 
which party was first to invent. For this reason the novelty and nonobviousness of an 
invention are evaluated, in theory, as of its ‘invention date’ which might differ from the 
actual filing date. (Mueller, 2006; United States Code, Section 102 & 103 of title 35) 
Unites States patent applications also enjoy a ‘grace period’ (United States Code, 
Section 102(b) of title 35) comprising a one year time period. The inventor does not lose 
the rights for a patent if a patent application is filed within one year of making the 
invention public. (Mueller, 2006; United States Code, Section 102 & 103 of title 35) 
The nonobviousness requirements are defined in United States Code, Section 103 of 
title 35 (Appendix 11). In practice, it states that the invention must not be obvious for a 
man skilled in the art at the time of invention. So the invention must represent enough 
qualitative advance over earlier technology. (Mueller, 2006; United States Code, 
Section 103 of title 35) 
3.6. United States patent infringement actions 
According to United States Code, Section 271 of title 35 (Appendix 12) a patent 
infringement occurs when someone without authority makes, uses, offers to sell, or sells 
any patented invention within the United States, or imports into the United States any 
patented invention, during its grant term. United States District Courts have jurisdiction 
over patent infringement lawsuits. Local patent rules and jury demographics have 
however made some jurisdictions more attractive to patent plaintiffs. Appeal of the 
District Court’s decision can be made to the Federal Circuit and in theory an appeal 
from the Federal Circuit’s decision can be made to the Supreme Court, but in practice 
the majority of the latter are denied. (Hoyng & Eijsvogels, 2007; United States Code, 
Section 271of title 35) 
An alternative way to solve patent disputes is via the International Trade Commission 
(ITC). A patent owner whose rights are being infringed by a product, which is being 
imported into or out of the United States, can file a petition with the ITC according to 
USC Section 1337 of Title 19 (Appendix 13). The complaint will be investigated by the 
ITC which can issue a binding judgment and order the defendant to cease the 
infringement. The ITC proceedings are becoming a more popular forum for patent 
infringement cases because they cost less than proceedings via court and they are also 
more time-efficient. One of the major disadvantages for a patent owner using the ITC is 
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that they can not recover any damages because injunction is the only available remedy. 
In principle, the defensive methods available via court are also available via ITC and the 
appeal will follow the same route as well. Figure 11 shows the U.S. court and ITC 
system for infringement actions. (Prescott, 2006; United States Code, Section 1337 of 
title 19) 
District Court 
 
 
Figure 11. United States Court and ITC system 
Numerous judicial decisions provide that the analyzing of patent infringement is a two-
step process comprising: (1) interpretation of the patent claims and (2) comparison of 
the properly interpreted claims with the accused device. The claim interpretation is to be 
performed by the judge and many district courts now carry out their claim interpretation 
responsibilities in the context of a separate pre-trial hearing, usually referred to as a 
“claim interpretation hearing” or a “Markman hearing”. The second step of the patent 
infringement analysis requires that each limitation of the properly interpreted claim be 
compared to the accused device. Infringement cannot be determined by comparing the 
claimed and accused devices as a whole, but the analysis must be performed on a 
limitation-by-limitation basis. If even a single limitation is not met in the accused 
device, there cannot be an infringement. It should be noted that as a common law 
country, the precedents play an important role when interpreting the claims. (Mueller 
2006, pp. 267-326) 
3.7. Defensive methods in United States 
3.7.1. Reexamination 
Reexamination, particularly ex parte reexamination, was established by legislation in 
1980. The purpose was to provide a relatively low-cost alternative to federal court 
litigation in which to resolve certain questions on validity. Currently, there are two 
reexamination options available, ex parte reexamination and inter partes reexamination. 
Ex parte reexamination can be requested by anyone, even the patent owner, but inter 
partes reexamination can be requested only by third parties. The reexamination request 
Supreme Court Federal Circuit
ITC 
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should include prior art that must raise a substantial new question of patentability. If a 
substantial new question of patentability exists, the USPTO will issue an order for 
reexamination. Therefore, the prior art should preferably be new compared to the cited 
prior art which the USPTO has already examined. A request for reexamination can be 
based only on prior art consisting of patents or printed publications which means that 
patentability can be challenged using only lack of novelty or obviousness criteria. 
(Mueller 2006, pp. 256-264; Greenlief, 2008; Sharer & Mauk, 2008) 
One disadvantage in an ex parte reexamination is that the third party requestor is not 
entitled to any participation once the examination begins and the requestor can not 
appeal the final decision. In an inter partes reexamination the third party requestor is 
allowed to participate throughout the reexamination offering comments on the issues in 
office actions and to rebut contentions made by the patent owner during examination of 
the claims. Also the decision can be appealed to the Board of Appeals and Interferences 
(BAI) and from there to the Court of Appeals for the Federal Circuit. (Mueller 2006, pp. 
256-264; Greenlief, 2008; Sharer & Mauk, 2008) 
Reexamination may be a good option when the reexamination request is based on one or 
more good references that provide strong invalidity and obviousness arguments. Ex 
parte reexamination is cheaper than inter partes reexamination, the former costing 
normally less than $50,000 and the latter normally less than $200,000. But as the inter 
partes reexamination has additional advantages which may justify the increased cost. 
Both reexamination procedures take usually less than two years to complete. (Heyman, 
2005; Sharer & Mauk, 2008) 
3.7.2. Interference action 
In the case where two companies have both individually filed patent applications 
claiming coverage to a same invention, the one who thinks they have invented the 
patented idea first can file an interference action with the USPTO. Interference is an 
action where a company can claim that they are the first to invent what has been 
claimed in a patent (either pending or granted patent). The interference action can then 
be used to have the other party’s patent either invalidated or to be modified to cover 
usually a much less broad idea than initially attempted. Both results may prevent any 
possible infringement of the other party’s patent. (Mueller 2006, pp. 157-162; Sharer & 
Mauk, 2008) 
An interference can be provoked in the USPTO either between two pending patent 
applications or between a pending patent application and an issued patent. In any case, 
the company seeking the interference must have a pending application. If the company 
does not have a pending application in the USPTO, a re-issue application can be filed 
(subject to certain time limits) based on the company’s issued patents and the re-issue 
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application can be used to provoke an interference. (Sharer & Mauk, 2008; Heyman, 
2005) 
In order to provoke an interference the applicant must met the following criteria 
according to Heyman (2005): 
• The applicant’s claims of the patent application must claim the same subject 
matter as one or more claims in the other party’s patent.  
• The patent application used to provoke the interference must be filed within 
one year of the grant date for the patent or within one year of the 
publication date of the published patent application. 
 
Once the criteria has been met, the company notifies the USPTO examiner about the 
interference intention and the examiner will suggest the interference to the Board of 
Appeals and Interferences (BAI). The Board will decide if an interference should be 
declared. If the interference is declared, the parties will proceed to a hearing in front of 
the BAI. The hearing is similar to a trial and the BAI weighs all the evidence presented 
by the parties. The parties are identified as senior and junior parties, based on filing 
dates of their inventions, i.e. the patentee whose patent application has the earlier filing 
date is referred to as the senior party and the other applicant as the junior party. The 
heavier burden of proof will be on the junior party. The interference process can take a 
year or more before the actual decision is declared. Appeal of the final decision may be 
filed to the Federal Circuit. (Sharer & Mauk, 2008; Heyman, 2005) 
An interference provides several advantages over litigation focused on invalidity. For 
example, the interference is conducted by the USPTO which has more experience in 
deciding priority of invention contests than the district courts. The BAI typically 
consists of individuals having technical degrees and in some cases legal degrees and 
they are experts in the USPTO rules and procedures. On the other hand, very few 
federal district court judges have technical degrees and are familiar with USPTO rules 
and procedures. In some cases, an interference proceeding may be used as a good basis 
for a motion to stay a patent infringement lawsuit. (Sharer & Mauk, 2008; Heyman, 
2005) 
A disadvantage of an interference proceeding is that the BAI may cancel one or more 
claims of the company’s own pending application and give an even stronger position to 
the other party in a subsequent infringement litigation. Also, the interference is more 
expensive than a reexamination procedure costing generally less than $1,000,000. 
(Sharer & Mauk, 2008; Heyman, 2005) 
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3.7.3. Invalidation via court 
A granted patent is always presumed to be valid, but it can be found invalid if it does 
not meet the requirements of patentability described in United States Code, Sections 
101-103 of title 35 (described in chapter 3.5) or due to deficiencies in the specification 
and claims, as specified in United States Code Sections 112 of title 35 (Appendix 14), 
or for failing to comply with the requirements of reissue as defined in United States 
Code Sections 251 of title 35 (Appendix 15). (Hoyng & Eijsvogels, 2007; Grossman & 
Hoffman 2005, pp. 995-1015) 
Validity of a granted patent is most often challenged in response to infringement 
lawsuits and therefore the same court will analyze and decide on both validity and 
infringement. All invalidity actions require the patent challenger to prove its case by 
clear and convincing evidence. The Supreme Court has characterized clear and 
convincing evidence as evidence which produces in the mind of the trier of fact an 
abiding conviction that the truth of the factual contentions is highly probable. The most 
common invalidity defenses are those based on prior art. The claims of the patent are 
anticipated under United States Code, Sections 102 of title 35 (Appendix 10), when a 
single prior art reference discloses every limitation of the claimed invention, either 
explicitly or inherently. To establish anticipation, one must identify the elements of the 
claims and determine their meaning in light of the specification and prosecution history. 
(Hoyng & Eijsvogels, 2007; Grossman & Hoffman 2005, pp. 995-1015) 
The deficiency defense (Appendix 14) focus is different from the prior art defenses. 
These invalidity defenses are established by showing that the specification fails to 
provide the best mode or an enabling description of the invention or that the claims fail 
to clearly point out the invention. The reissue requirements (Appendix 15) deny for 
example double patenting and any enlargement of scope of the claims of the original 
patent if the reissue was filed more than two years from grant of the patent. The default 
is that claims must be construed the same whether the purpose is to demonstrate patent 
infringement or validity of the patent. (Hoyng & Eijsvogels, 2007; Grossman & 
Hoffman 2005, pp. 995-1015) 
Duration of the proceedings including infringement and/or invalidity of the patent takes 
usually 2-3 years for the full litigation process. The cost of infringement and/or 
invalidity proceedings are approximately $1,000,000 – $25,000,000 in the District 
Court. (Hoyng & Eijsvogels, 2007) 
3.7.4. Antitrust 
If the patentee violates the antitrust laws in connection with the use of its patent, an 
accused infringer may assert an antitrust counterclaim. Conduct that may violate the 
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antitrust laws include enforcing a patent known to have been obtained through fraud or 
to be invalid, tying the purchase of an unpatented good to a license under a patent, or 
using the patent to violate the antitrust laws in any other way. Antitrust counterclaims in 
patent cases are most commonly brought under the Sherman Antitrust Act (USC title 15 
sections 1-7), section 2 (Appendix 16) which prohibits acquisition or maintenance of 
monopoly power through anticompetitive conduct. (Grossman & Hoffman 2005, pp. 
1019-1024; Mueller 2006, pp. 370-380) 
Patents have been mistakenly viewed as “monopolies”, such that accused infringers of 
patents have asserted that patent owner’s enforcement of their “monopoly” rights 
represented a violation of the antitrust laws. The law further forbids contracts or 
conspiracies in restraint of trade and monopolization or attempts to monopolize. The 
monopoly can be proven by showing the possession of a monopoly power in the 
relevant market and the willful acquisition or maintenance of that power as opposed to 
growth or development. The courts have been reluctant to impose the penalties on 
companies that have gained substantial market power without having engaged in 
conduct that otherwise violates the antitrust laws. The law does not aim to penalize 
companies that have succeeded because of superior foresight and skills. As the antitrust 
defense will be heard by the same court where the patent infringement and invalidation 
action is handled, the cost and duration of the proceedings are approximately the same.  
(Mueller 2006, pp. 370-380; Teece 2000, p. 182) 
3.7.5. Patent misuse 
Patent misuse defense can be brought up in a patent infringement litigation case if the 
accused infringer can show that the patentee has impermissibly broadened the scope of 
the granted patent with anticompetitive effect. A successful result of this defense tactic 
is that the enforcement of the patent is barred until the misuse is purged. The misuse 
must be pleaded in any action involving validity or infringement. However, misuse 
often accompanies an antitrust claim. So that even if the patentee’s act may not be 
violating the antitrust law, it may still constitute patent misuse. Misuse focuses 
primarily on the patentee’s behavior in expanding the scope of its rights beyond the 
statutory patent grant, while antitrust measures the impact of that behavior on the 
marketplace. As the patent misuse defense will be heard by the same court where the 
patent infringement and invalidation action is handled, the cost and duration of the 
proceedings are approximately the same. (Grossman & Hoffman 2005, pp. 1024-1029; 
Mueller 2006, pp. 355-362) 
3.7.6. Patent exhaustion 
The United States views the patent exhaustion in a more restricted way than the 
European Union. Where the European Union is applying a community-wide exhaustion, 
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the United States is applying a domestic exhaustion. The domestic exhaustion means 
that after the patentee or another authorized party sells a product in the domestic market, 
the patentee has no longer any enforceable right to control the disposition or profit from 
the subsequent resale of the same item within the domestic market. As the patent 
exhaustion defense will be heard by the same court where the patent infringement and 
invalidation action is handled, the cost and duration of the proceedings are 
approximately the same.  (Mueller 2006, pp. 439-440) 
3.7.7. Inequitable conduct 
The patentee is under a duty of candor in dealing with the USPTO and inequitable 
conduct is a breach of that duty. The USPTO has revised its applicable regulations over 
the years, so it is important to identify the rule that was in effect when the alleged 
inequitable conduct occurred. If the inequitable conduct is proven, the patent is 
unenforceable. The inequitable conduct defense process involves providing two 
threshold elements: (1) materiality of undisclosed information and (2) intent to deceive 
the patent examiner. Once materiality and intent are established, the court performs a 
balancing test and considers all circumstances before deciding on inequitable conduct. 
(Grossman & Hoffman 2005, pp. 1015-1019) 
Finding information or material known by the patentee, whom the reasonable examiner 
would have considered important in deciding whether to grant the patent, is one task 
that the accused infringer must come up with. The intent to deceive a patent examiner 
with the undisclosed material or information follows after that. Publications raised by 
examiners in other countries are a usable source for finding any such evidence. As the 
inequitable conduct defense will be heard by the same court where the patent 
infringement and invalidation action is handled, the cost and duration of the proceedings 
are approximately the same. (Grossman & Hoffman 2005, pp. 1015-1019) 
3.7.8. Laches and equitable estoppel 
The laches defense can be used in situations where the patent owner delays bringing the 
infringement suit for more than six years after the date the patent owner knew or should 
have known about the infringing activities done by the defendant (Mueller 2006, pp. 
339-342). By using the laches argument, the accused infringer can stop any recovery of 
damages relating to patent infringement occurring prior to the filing of the infringement 
action (Mueller 2006, pp. 339-342). Two requirements need to be fulfilled in order for 
the defendant to use the laches defense. These requirements are according to Grossman 
& Hoffman (2005, p. 1030): 
1. Unreasonable and inexcusable delay by the plaintiff in bringing the patent 
infringement suit; and 
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2. The defendant was materially prejudiced due to the plaintiff’s delay. 
The material prejudice can take a form of evidentiary prejudice, such as loss of 
documents and recollections of witnesses over time. The prejudice can also be 
economic, as where the defendant has encountered change in its economic position 
during the delay period. For example, the defendant has made substantial investment in 
manufacturing facilities needed to produce the infringing product before the patent 
infringement suit was filed. (Grossman & Hoffman 2005, p. 1030) 
The scope of defense is a bit different in equitable estoppel, than in laches (Mueller 
2006, p. 343). In equitable estoppel the focus is not on the plaintiff’s unreasonable delay 
in suing, but rather on the unfairness of the plaintiff’s actions in misleading the 
defendant into believing that it would not be sued and the defendant’s reliance on it 
(Mueller 2006, p. 343). The required elements of equitable estoppel according to 
Grossman & Hoffman (2005, p. 1030) are: 
1. The plaintiff misleads the defendant into reasonably inferring that the 
plaintiff does not intend to enforce its patents against the defendant, and 
2. The defendant relies on the plaintiff’s misleading conduct, and 
3. Due to its reliance, the defendant will be materially prejudiced if the plaintiff 
is allowed to proceed with its infringement claim. 
If the equitable estoppel defense is sustained, the result is that the plaintiff’s 
infringement action is completely barred. Thus the penalty is considerably more severe 
than that for laches. As the laches and equitable estoppel defenses will be heard by the 
same court where the patent infringement and invalidation actions are handled, the cost 
and duration of the proceedings are approximately the same. (Grossman & Hoffman 
2005, p. 1030; Mueller 2006, p. 343) 
3.8. Chinese patents 
Compared to western countries, China has protected intellectual property only for a 
relatively short time. In 1984, China passed its first patent law that helped to create a 
similar patent system as used in Europe and Japan. A first amendment to the law was 
done in 1992, when the scope and length of the patent protection were extended. In 
2000, the Patent Law was again amended in order for China to fulfill its obligations 
under TRIPS (Trade-Related Aspects of Intellectual Property Rights) and to become a 
member of the World Trade Organization (WTO). In accordance with TRIPS 
requirements, the amendments provided patent holders with the right to obtain a 
preliminary injunction against the infringing party before filing a lawsuit. The law also 
stipulated standards to compute statutory damages. In 2008, the patent law was 
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amended again to be more in line with other developing countries. (Hu & Jefferson, 
2009) 
After the 2000 patent law amendment, invention patent applications from both domestic 
and foreign inventors have grown at an annual rate of 23%. Several reasons for this 
patent explosion can be found, such as China’s intensification on R&D and foreign 
direct investment, but the most significant has definitely been the China’s patent law 
amendments. (Hu & Jefferson, 2009) 
The State Intellectual Property Organization (SIPO) has the administrative control of 
patents and utility models. SIPO is responsible for examination and approval of IPR, 
interpretation of IP laws, supervision of IP activities and administrative settlement of IP 
disputes. (Liu, 2005) 
The SIPO grants three types of patents: invention patents, utility models and design 
patents. The invention patents, herein called patents, have 20 year protection and the 
following patentability criteria (Cohen & Zhu, 2008; SIPO, 2006):  
1. Novelty 
• Mixed Novelty for patents filed before Oct 1, 2009 
• Absolute novelty for patents filed on or after Oct 1, 2009 
2. Inventiveness 
3. Usefulness 
Mixed Novelty means that a printed publication anywhere in the world destroys 
novelty, but oral disclosure or prior public use is novelty destroying only if it took place 
in China. The new patent law (effective as of October 1, 2009) is congruent with the 
European Patent system, requiring an absolute novel requirement, meaning that prior 
public use anywhere in the world is considered as novelty destroying. Inventiveness 
means that the invention has prominent and substantive distinguishing features and 
represents a notable progress or improvement. Usefulness means that the invention can 
be made or used and can produce positive results. (Cohen & Zhu, 2008, SIPO, 2006) 
China also applies with the First-to-File rule, which is similar to that used by the 
European Patent Convention. However, a grace period concept is used in China as in the 
United States, meaning that the invention does not lose its novelty so long as an 
application is filed within six months of the occurrence of a triggering event, which 
includes the following: 
1. The invention was first exhibited at an international exhibition sponsored or 
recognized by the Chinese Government; 
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2. The invention was first made public at a prescribed academic or 
technological meeting; 
3. The invention was disclosed by any person without the consent of the 
applicant 
(Cohen & Zhu, 2008, SIPO, 2006)  
The patentable subject matter under Chinese law means any new technical solution of  
1) A product; 
2) A process; or 
3) Improvement of the product or process. 
(Cohen & Zhu, 2008) 
The subject matter excluded from patentability are: 
• Any invention-creation that is contrary to the laws of the state or social 
morality or that is detrimental to public interest 
• Scientific discoveries 
• Rules and methods for mental activities 
• Method for the diagnosis or for the treatment of diseases 
• Animal and plant varieties 
• Substances obtained by means of nuclear transformation.  
(Cohen & Zhu, 2008, SIPO, 2006) 
3.9. Chinese patent infringement actions 
Even if China has established intellectual property laws that generally meet 
international standards, weak enforcement continues to frustrate efforts to protect IP in 
China. Piracy and counterfeiting levels continue to be at a high level and impact 
products, services, brands and technologies in many types of industries. (Greguras, 
2007) 
Historically, China’s culture perceived copying and imitation as an effective way of 
learning, and monopoly of knowledge was therefore disagreeable to the moral standards 
in China. Confucian ethics may have had an influence on the people and how they 
advocate that copying is widely practiced as a legitimate means of learning and sharing. 
(Yang, 2005) 
Furthermore, before recent patent reformation, all patents were owned by the 
government and could be shared by any company that was willing to use them. This was 
even encouraged by the government and this might be one reason why Chinese 
companies even nowadays think that intellectual property is there for anyone to use. The 
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recent media exposure of intellectual property infringement and governmental publicity 
has however increased people’s awareness about the significance of intellectual 
property. (French, 2005; Yang, 2005) 
The people’s courts of China are responsible for the judicial enforcement of intellectual 
property in China. More specifically, invention patent litigation is usually first brought 
to the Intermediate People’s Courts in provincial cities where the alleged infringers 
reside or where the infringement has occurred. Appeal from the Intermediate People’s 
Court decision can be filed with the High Court within 15 days (if the party is Chinese) 
or within 30 days (if the party is foreign) after service of the intermediate courts 
decision. A petition from the High Court decision can be filed to the Supreme Court, 
requesting a retrial. It is entirely up to the Supreme Court to decide whether to accept 
the petition. Any such petition must be filed within two years after a court decision 
becomes legally effective. Figure 12 shows the Chinese court system for infringement 
actions. (Yang, 2003; Hoyng & Eijsvogels, 2008) 
 
High Court Supreme Court Intermediate 
Court 
 
Figure 12. Chinese court system 
When a court has accepted a lawsuit, it will serve the defendant the complaint. After 
being served, the defendant is required to file an answer to the court within 15 days (if 
the defendant is Chinese) or within 30 days (if the defendant is foreign). What is 
important for the prescribed time period is that any request for stay of the patent 
infringement proceedings should be filed within the time period to enable the court to 
consider the request under Supreme Court provisions. An infringement action will last 
between 6 and 18 months in the first instance, if not stayed, and will cost approximately 
$50,000 – $150,000. (Bai et al, 2007; Hoyng & Eijsvogels, 2008) 
As the intellectual property law and its enforcement are still relatively new in China, it 
is quite risky, especially for foreign companies to file infringement suits in China 
against Chinese companies. Lawyers who represent foreign companies in intellectual 
property disputes in China have discovered that there are major loopholes in Chinese 
law and in the patent system. The local and provincial governments sometimes 
subsidize patent filings for local companies and advice them on how to beat foreign 
claims of infringement. As Chinese lawyer Xian Wang expressed the situation, “Once 
upon a time, the counterfeiters in China ran away when you came after them. Today 
they don’t run away. Indeed, they stay put and they sue us. More and more Chinese 
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companies are taking so-called legal approachs, taking advantage of serious weaknesses 
in the Chinese legal system”. (French, 2005)  
3.10. Defensive methods in China 
3.10.1. Invalidation 
Unlike Europe, China does not have a procedure for opposing patents. Instead, the only 
way to challenge a granted patent is by requesting patent invalidation. This is done by 
filing a petition in writing to the Patent Re-examination Board of the SIPO, which will 
handle the requests and make a decision regarding the validity. This differs significantly 
from other countries, where the invalidation procedure is handled by the judiciary. In 
fact, it is comparable to the reexamination procedure in the United States. In China, the 
judiciary does not admit invalidation requests. An appeal against the decision of the 
patent re-examination board, however, can be made to the judiciary, in compliance with 
the mandatory rules under TRIPS. The appeal to the people’s court must be made within 
three months after receiving the notification of the decision. (Cohen & Zhu, 2008) 
The petition should include the grounds of invalidity and supporting evidence. Any 
supplemental grounds and evidence can be filed within one month from the date of 
filing the petition. Although many forms of evidence are accepted by the Patent Re-
examination Board, documentary evidence with an unambiguous publication date would 
be the most reliable for the invalidation proceedings. (Cawthorn, 2008; SIPO, 2006) 
The grounds for invalidity can be divided into two broad categories, namely substantive 
and technical grounds. (Cawthorn, 2008; SIPO, 2006) 
1. Substantive grounds 
• Non-patentable subject matter 
• Lack of novelty, inventiveness or practical utility 
2. Technical grounds 
• Added subject matter 
• Insufficient disclosure of description 
• Claim lacking support 
• Claim lacking clarity and/or succinctness 
• Double patenting 
• Proceedings 
 
Non-patentable subject matter was identified already in China patents chapter 3.8. Due 
to the recent modifications of the patent law, the absolute novelty requirement applies to 
patents filed on or after October 1, 2009. Therefore, the invalidity arguments can not be 
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based on oral disclosure or prior public use which took place outside of China for 
patents filed before October 1, 2009. But a printed publication published anywhere in 
the world destroys novelty of patents filed at any point of time. (Cawthorn, 2008; Cohen 
& Zhu, 2008) 
Also, inventiveness can be used as a ground for invalidation. In this case, the invention 
does not possess outstanding substantive characteristics and notable improvement over 
the state-of-the-art. In practice, a three-step test is adopted during invalidation 
proceedings: (1) ascertaining the closest prior art, (2) identifying whether there are any 
differences between the invention and the closest prior art, and (3) determining whether 
any differences are obvious to a person skilled in the art. (Cawthorn, 2008; Cohen & 
Zhu, 2008) 
Technical grounds offer usable arguments for invalidation as well. The patent 
application should not add subject matter that extends beyond the content of the 
application as filed, nor should the claims be amended in a way that limits the scope of 
protection using a feature which has not been described in the description. Double 
patenting is also a common practice in China. It is allowed to file both utility model 
patents and invention patents of the same invention, but once invention patent is 
granted, the applicant should withdraw the utility model patent in order to prevent 
double patenting. (Cawthorn, 2008; Cohen & Zhu, 2008) 
From the various grounds available for use, an attack on the lack of novelty and/or 
inventiveness, and added subject matter would probably have the most weight, 
especially given the very limited scope of allowable amendments available during 
invalidation proceedings. The patentee has very limited flexibility to make amendments 
to the patent, only amendments to delete claims, to combine claims or to delete 
alternative features of a claim are allowed, provided that there is no broadening of the 
original claims after amendments. (Cawthorn, 2008)  
The Patent Re-examination Board can make one of the following decisions: a) the 
patent is totally invalidated, b) the patent is partially invalidated, or c) the patent is 
valid. In 2007, there were 354 petitions for patent invalidation filed in China and based 
on unofficial estimates, about 50-60 % of the petitions were successful. (Cawthorn, 
2008) 
Using invalidity as a defense for infringement action is a normal and popular action, but 
it should be noted that the infringement court is not obligated to stay the infringement 
proceedings until the invalidation action has been resolved. The request for invalidation 
should be filed within 15 days (if defendant is Chinese) or within 30 days (if defendant 
is foreign) after being served with the complaint in order to even have the chance for 
getting the infringement proceedings stayed. It is entirely up to the court to decide 
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whether or not to grant the request for stay. The Supreme Court has provided general 
rules on how a court should decide on this. If the case relates to a utility model patent or 
a design patent, the court generally should rule to stay, waiting for the result of the 
invalidation proceedings. Whereas, if the case relates to an invention patent, the court 
may decide not to stay the infringement proceedings. (Bai et al, 2007; Hoyng & 
Eijsvogels, 2008) 
For a invention patent the court would examine the merits of the defendant’s request for 
invalidation and all the evidence before rendering a decision to stay the proceedings. 
Generally, if the novelty of the invention patent is challenged with solid evidence, the 
court may rule to stay, otherwise, the court would generally rule to reject the request for 
a stay. In practice, less than 10% of invention patent infringement cases have been 
stayed in light of invalidation proceedings. (Bai et al, 2007; Hoyng & Eijsvogels, 2008) 
It usually takes about 6 to 36 months to complete patent invalidation proceedings and it 
will cost approximately $15,000 – $25 000. Therefore, if there is a parallel patent 
infringement and invalidation case, which is not stayed by the court, usually the 
infringement proceedings complete before the invalidation proceedings. It should also 
be noted that even if the patent is found invalid, it will not have retroactive effect on any 
judgment on patent infringement that has been pronounced and enforced by the people’s 
court. This is one of the main reasons why defendants usually make great efforts to try 
to have the infringement proceedings stayed. The invalidation action can also be filed if 
no litigation action is ongoing, and in that case there is no deadline for filing it. (Cohen 
& Zhu, 2008; Hoyng & Eijsvogels, 2008; Antila, 2009) 
3.10.2. IP abuse and anti-monopoly issues 
While a patent grants a monopoly that enables the patentee to prevent others from 
exploiting the innovation, a competition law (i.e., China’s antimonopoly law), aims to 
prevent monopoly situations and to safeguard fair market competition. The TRIPS 
agreement sets up general principles for dealing with IP abuse and anticompetitive 
activities, but left it for each member state to develop specific law and policies to define 
the concepts and to regulate the activities of IPR holders when commercializing their 
intellectual property products and services. China’s law was amended to include the 
principles only two years ago and it came into effect on August 1 2008. Therefore, it is 
yet unclear how the defense can be applied in real situations. (Tian, 2009; Nicholson & 
Liu, 2008) 
From Article 8 of the TRIPS agreement (Appendix 17) it is clear that the scope of IP 
abuse is very broad, and the Chinese wording of the law is similarly vague. Therefore, 
China may consider conduct of IPR holders to be abusive regardless of whether the 
enterprise in question dominates the market or not, and regardless of whether there is an 
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anticompetitive use. This may serve as a sound defense to patent infringement claims, 
especially for Chinese domestic companies. (Tian, 2009; WTO, 1994) 
The anti-monopoly law may have similar effects. Many multinational companies fear 
that Chinese companies may restrain foreign IP holders from enforcing their intellectual 
property rights against them by claiming that the bringing of the infringement action 
against them constitutes an abuse of these asserted rights or a restriction of market 
competition. The claim of IP abuse or monopolistic position of a third party can be filed 
to the Intermediate Court. If the complaint is done when there is patent infringement 
litigation ongoing it may stay the infringement proceedings until the anticompetitive 
issue is investigated. As the IP abuse and anti-monopoly defense will be heard by the 
same court where the patent infringement action is handled, the cost and duration of the 
proceedings are approximately the same.  (Tian, 2009; Nicholson & Liu, 2008) 
3.10.3. Compulsory licenses 
A compulsory license may be requested by any party who has been unable to obtain a 
voluntary license on reasonable terms within a reasonable period of time. Request for a 
compulsory license can be filed to the SIPO with proof that the applicant has not been 
able to conclude a licensing contract on reasonable terms with the patentee. The 
compulsory license can also be requested in situations where a later filed patented 
invention (owned by the compulsory license requestor) is technically more advanced 
than another earlier filed patented invention and the exploitation of the later filed 
invention is dependent on the exploitation of the earlier filed invention. In that case, the 
SIPO may grant a compulsory license to exploit the earlier filed invention. (Grubb, 
2008; Cohen & Zhu, 2008) 
If the compulsory license is granted, the licensee is obligated to pay the patentee a 
reasonable exploitation fee. The amount of fee is decided between the parties through 
consultation, but in case they are unable to reach an agreement, the SIPO will give a 
ruling of it. In practice, there have not been any compulsory license requests after 1985 
(when the patent law became effective) based on unsuccessful licensing negotiations, so 
it is unknown how the SIPO would review and decide on such an application. 
Compulsory licenses based on the dependency of an earlier filed and later filed 
invention has never been granted in practice, perhaps because it is hard to measure the 
advancement between the two inventions. As the compulsory license defense will be 
heard by the same court where the patent infringement action is handled, the cost and 
duration of the proceedings are approximately the same.  (Hoyng & Eijsvogels, 2008; 
Cohen & Zhu, 2008) 
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3.10.4. Prior use 
If the defendant is able to demonstrate that they had made necessary preparations for 
making and using the patented invention in China before the priority date of the patent, 
the defendant may continue to utilize the patented invention without being deemed to 
have infringed the patent. The Beijing High Court has developed a number of tests to 
determine whether there is a prior use and put some limitations on the prior use: 
• “Necessary preparations” mean that product design drawings and manufacturing 
processes have been completed and special equipment and moulds have been 
prepared, or testing manufacturing has been completed; 
• The right of prior use is limited to the original scope only, which means that it 
should be limited to the actual production volume or production capability 
before the filing date of the patent at issue. Exceeding the original scope 
constitutes infringement of the patent; 
• The prior product or process was obtained by the prior user’s own independent 
research or by other legal means, and should not be obtained from the patent 
holder through inappropriate means; and 
• The prior user can not license or transfer the prior technology to others, unless it 
is transferred together with the prior use’s company.  
(Hoyng & Eijsvogels, 2008) 
 
As the prior use defense will be heard by the same court where the patent infringement 
action is handled, the cost and duration of the proceedings are approximately the same. 
(Hoyng & Eijsvogels, 2008) 
3.10.5. Patent exhaustion 
China is one of the few countries in the world to recognize international exhaustion. 
Meaning that the patent owner’s rights are extinguished at the first authorized sale of a 
patented item anywhere in the world, and that subsequent importation of that same item 
into another country cannot be legally wrong. Meaning that when, for example, a 
company sells products in Africa at a discounted price any third party can buy the 
products and import them back to the company’s home country and sell the same items 
there. (Mueller 2006, pp. 441-442) 
The international exhaustion system is usually supported by the fact that consumers 
benefit from the price competition created by parallel imports. International exhaustion 
is a controversial idea to the traditional thinking that patent rights are merely national, 
not international, in scope and that such rights begin and end at national borders. As the 
patent exhaustion defense will be heard by the same court where the patent infringement 
 50   
action is handled, the cost and duration of the proceedings are approximately the same.  
(Zhu, 2009; Mueller 2006, pp. 441-442) 
3.10.6. Declaration of non-infringement 
Declaratory judgment on non-infringement can be requested in China, according to Bai 
et all (2006), based on one of the following grounds: 
• Where a person who is making or is going to make a product or use a process 
requests a patentee to determine that his act does not or will not infringe the 
patentee’s patent, and in a reasonable manner, provides technical documents 
and information necessary for making the determination but the patentee fails to 
reply within a reasonable time limit or refuses to make a non-infringement 
determination, the person may bring an action in a people’s court to request a 
declaration that his act does not or will not constitute infringement of the patent 
at issue. 
• Where a patentee or an interested party sends a warning letter accusing 
infringement to another person, the warned party may bring an action in a 
people’s court to request a declaration of non-infringement  
• Where an act of warning by a patentee or an interested party impinges upon the 
legal rights of the warned party, the warned party may also request a people’s 
court to order the warning party to cease impingement, compensate for 
damages, eliminate ill influence, and/or make an apology. 
 
This form of defense has been available in China since 2002, and it can have many 
advantages to the defendant especially if it is used prior to infringement litigation. By 
filing a non-infringement declaratory judgment in China, the defendant can select the 
most convenient intermediate court, requiring that the later filed infringement action 
also take place at the same court even if the plaintiff files it with another intermediate 
court. As the declaration of non-infringement defense will be heard by the same court 
where the patent infringement action is handled, the cost and duration of the 
proceedings are approximately the same.  (Bai et all, 2006; Hoyng & Eijsvogels, 2008) 
3.11. Comparing the defensive methods 
Table 3 summarizes the jurisdictional availability of the defensive methods presented 
earlier. Category “Europe” has been used if the method available for European patent is 
handled in a centralized way (via EPO). On the other hand, when the method available 
for European patents is handled on national level using national legislation, the 
countries having the method available have been identified. For the United States and 
China it has not been separately identified if the method is available via the national 
patent office or via court. 
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Table 3. Defensive methods available in each country 
 Europe Germany France United Kingdom 
United 
States China 
Opposition X      
Intervention X      
Third party 
observations X      
Patent 
revocation  X X X   
Compulsory 
licenses  X X X  X 
Patent 
exhaustion  X X X X X 
Prior use  X X X  X 
Declaration of 
non-
infringement 
  X X  X 
Reexamination     X  
Interference 
action     X  
Invalidation      X X 
Antitrust     X  
Patent misuse     X  
Inequitable 
conduct     X  
Laches and 
equitable 
estoppel 
    X  
IP abuse and 
antimonopoly 
issues 
     X 
 
As can be seen from the table above, there are big jurisdictional differences on which 
defensive methods are available. In addition to the availability of a method, the 
defending party has to also consider the positive and negative effects of each of the 
methods, and the possibility to use several methods in parallel. Some of these aspects 
are discussed in the following. 
The person or company filing third party observations for a European patent will not 
become a party of the proceedings and can therefore not appeal the decision made by 
the examiner. Often third party observations lead to a stronger patent because the 
patentee can amend the claims or because the prior art presented by the observer is now 
been considered by the examiner when allowing the patent. After the prior art has been 
considered by an examiner, it is unlikely that the use of the same prior art will be 
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successful in revocation or opposition proceedings. In general, it is better to bring up 
any such observations in opposition or revocation actions.  
Opposition gives an opportunity to attack a European patent on a central basis with the 
objective of having it revoked or limited by amendment for all the countries to which it 
applies, whereas national revocation actions can only revoke or limit the patent scope in 
the specific country. If there is a need for invalidating a European patent by a revocation 
action in more than one of the designated countries, the cost will be much higher than if 
the European patent is opposed. It should also be noted that in different countries the 
patentability criteria can be interpreted differently, therefore prior art used to revoke a 
patent in one country might not be as useful in another country and vice versa. In a 
revocation action the final decision is done by a judge, who may or may not have a 
technical background which could also influence the ruling. On the other hand, the EPO 
Opposition Division has a technical background and experience on interpreting the 
scope of the patent with respect to the prior art. Therefore, opposition and intervention 
are usually more convenient methods than revocation action.  
Compulsory license actions are extremely rare, both in Europe and China, and the grant 
of a compulsory license is even rarer. Therefore, the action cannot be considered as a 
viable solution.  
A prior use argument is usually brought as a defense in an infringement action in 
Europe and China in case the defendant has no better methods for defending itself. The 
disadvantage of using a prior use defense is that the use of an invention for infringing a 
product or method can be limited to the specific type it was when the invention was first 
filed, meaning that modifications can not be done to it later. 
Patent exhaustion is available in Europe, China and United States, but the grounds for 
applying it vary in each country. The United States applies a domestic exhaustion, 
European Union applies a community-wide exhaustion and China applies international 
exhaustion. Patent exhaustion is a relatively risk free defense method, but it can only be 
applied by resellers and importers. 
Declaration of non-infringement is quite usable in Europe, because it can be used to get 
a stay on infringement proceedings also in countries where the declaratory judgment for 
non-infringement is not even available. In China the grounds for applying declaratory 
judgment are significantly lower than in Europe. By applying the declaration of non-
infringement in China, before the plaintiff files a patent infringement action the 
defendant can select which court would be most beneficial for them, thus putting the 
plaintiff in a more disadvantaged position in pursuing its infringement claims. This 
makes it a very attractive defense method to be used in China. The disadvantage of 
using the declaration of non-infringement action in Europe and China is that if it is 
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allowed, it will only protect the defendant’s products as they were at the time of 
judgment. 
Ex parte reexamination in United States is comparable to the third party observations 
method in Europe, as they both have the same disadvantages of not allowing an access 
to the proceedings and that the requestor is not entitled to appeal the decision. Whereas 
the inter partes reexamination can be compared to the opposition method since in both 
cases the requestor is able to participate in the proceedings and is entitled to appeal the 
decision. This makes the inter partes reexamination a more appealing method to use 
than the ex parte reexamination. The downside of this defensive action is that the patent 
in question will become stronger if the re-examination material and the arguments made 
against it are not good enough to get the patent invalidated. This is true also for patent 
oppositions. 
An interference proceeding can be an appealing method to use in the United States, 
especially if the requestor has filed a similar patent application earlier than the third 
party. Interference proceedings are usually much shorter than reexamination and 
invalidation proceedings, so the decision can be received in a relatively short time. 
However, this method has its disadvantages as well, since the requestor’s own patent 
may be jeopardized in the proceedings. In some cases the risk is worth taking as the 
USPTO technical experts in interference proceedings usually have required knowledge 
to analyze the patents, whereas invalidation proceedings with a non-technical judge can 
have unpleasant results.  
Invalidity of a patent is commonly used in United States as a defensive argument in 
patent infringement cases. The good thing is that the same court will analyze both 
infringement and validity of the patent, making sure that the scope of the claims will be 
construed the same for both evaluations. The only disadvantage is that the judges might 
not have the needed technical experience to interpret the patent and infringing product 
or process. Therefore the inter partes reexamination or interference methods could very 
well be better defenses for infringement accusations. 
Antitrust issues relating to the monopolization have rarely been judged by the courts as 
the intention is not to penalize companies that have succeeded because of growth and 
development by their superior skills, unless it can be proven that the monopolistic 
position was gained by engaging in conduct that violates the antitrust laws. Therefore 
this defense can not usually be considered as a viable defense method. 
Patent misuse accompanies the antitrust claim on many occasions. Whereas the patent 
misuse focuses primarily on the patentee’s behaviour in expanding the scope of its 
rights beyond the statutory patent grant, the antitrust measures the impact of that 
behaviour. Hence, often if the patentee’s acts don’t violate the antitrust laws, they may 
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still constitute a patent misuse, making it a more viable defense method than the 
antitrust defense. 
 Inequitable conduct can sometimes follow with invalidation proceedings if it is found 
out that the patentee has intended to deceive the patent examiner by not disclosing 
relevant information. The problem, however, is to locate such material and to proof the 
conduct. 
Laches and equitable estoppel can be used in situations where the patentee has delayed 
bringing the infringement litigation. In laches the defense concentrates to the delay itself 
whereas the equitable estoppel focuses on the misleading acts of the patentee by 
pretending that they will not enforce their patent rights against them. In laches the 
method can only be used to stop recovery of damages prior to the infringement 
proceedings, but in equitable estoppel the method can be used to block the infringement 
action completely. 
The invalidation method in China is, unlike in other countries, handled by the patent 
administration, even though the possible appeal will then take place in court. The patent 
infringement and invalidation proceedings in China are close to those in Germany, 
where the two are also handled separately. This puts more pressure on the defendant to 
take good care of the invalidation proceedings in order to first get the infringement 
litigation stayed. However, the advantage in China is that the patentee has very limited 
flexibility to amend the patent claims in the case where good prior art is presented. It is 
generally better to raise any defenses in the infringement litigation than via other means, 
as the defenses will be handled together with the infringement proceedings. This could 
save the defendant from any requirements to pay damages based on infringement 
judgment if the patent is found invalid later.  
IP abuse and antimonopoly defense can be used to safeguard fair market competition. 
Because the anticompetitive law is quite recent in China, it is hard to predict how it can 
be used as a defense argument in patent disputes, but in case the plaintiff is a 
multinational company it might be worth trying to utilize this defense. Furthermore, it 
might not even have to be a company having a market dominant position in order to use 
this defense and the action may stay any infringement proceedings until the issue is 
investigated. 
In all countries, the defendant can plead an unlimited number of defenses in 
infringement litigation, meaning that it does not have to rely on only one of the 
defensive methods available. But in some jurisdictions, if a method available via the 
patent administrative is used, that could exclude some of the methods available via court 
proceedings. For example, in Germany an open opposition will exclude any national 
revocation action for the same patent. 
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4. CONCLUSIONS 
4.1. Results of the study 
The aim of this thesis was to discover different methods for defending against third 
party patents in the most litigious countries in the world. Based on this aim, research 
questions were defined. The purpose of this chapter is to evaluate the results of the 
study by summarizing the presented issues and making conclusions to answer these 
research questions:  
What role does the company’s intellectual property strategy play in relation to 
the likelihood of getting into a patent dispute? 
A value hierarchy developed by Davis and Harrison (2001) can be used to identify five 
levels of intellectual property strategies. Each level represents a different expectation 
that the company has about the contribution that its intellectual property function should 
make for supporting the company’s vision and strategy. Achieving a higher level in the 
value hierarchy will decrease the likelihood of patent litigation from competitors. On 
the highest level, the company should be well protected from any patent litigation. 
However, this works only in theory as only a few, if any, companies have ever reached 
the highest level. Furthermore, as the protection from third party patents will be based 
on the company’s own patent portfolio, it will not protect from patent trolls. Therefore, 
it can be concluded that the intellectual property strategy can protect against competitors 
but not necessarily against patent trolls. 
What are the defensive methods available to be used against a third party patent, 
and what are the prerequisites for their use? 
Defensive methods available in Europe, United States and China were presented in 
chapters 3.4, 3.7, and 3.10. Criteria for using them were defined in the same chapters. A 
cross table identifying the available methods in each country have also been created and 
presented in chapter 3.11. 
Compared to each other, what are the advantages and disadvantages of the 
defensive methods?  
The advantages and disadvantages of the methods were presented in chapter 3.11. The 
tables below (Tables 4 – 15) summarize the advantages and disadvantages of each 
 
 
 
available method and the prerequisites for their use. It provides guidelines for selecting 
defense methods to be used, but it should be noticed that the use of any defensive 
method should be investigated case by case in order to determine its effect on the 
efficient resolution of a patent dispute. 
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Table 4. Defensive methods available for European patents 
   T     i m     i n     g          
Methods for 
European 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion Additional Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
proceeding 
Cost of the 
proceeding 
Advantages / 
Disadvantages 
Opposition   X X X 
Within 9 months 
after the grant EPO 
Appeal to 
EPO 
Board of 
Appeal 
Grounds for the 
action are 
defined in EPC 
Article 100 
(Appendix 2)   
36-60 
months 
€80,000-
€120,000 
+ If successful, 
patent is revoked or 
limited by 
amendment for all 
the countries to 
which it applies 
+ Broad range of 
grounds to use 
+ EPO has technical 
experts to study the 
case 
Interven-
tion   X   X 
1) After opposition 
period has expired, 
but opposition is 
pending, and 
2) Within 3 months 
after being served 
with an 
infringement 
proceedings EPO 
Same as 
for 
opposition 
Same as for 
opposition 
Infringement 
proceedings of 
the patent have 
been instituted 
against the 
person or 
company 
Same as 
for 
opposition 
Same as 
for 
opposition 
Same as for 
opposition 
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Table 5. Defensive methods available for European patents 
   T      i m      i n      g          
Methods for 
European 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion Additional Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of the 
procee-
ding 
Advantages / 
Disadvantages 
Third-party 
observa-
tions X X X X 
1) After patent 
publication, while 
the patent is 
pending, or  
2) During 
opposition while 
the opposition is 
still pending and no 
decision has been 
made. EPO No 
Grounds for the 
action are 
defined in EPC 
Articles 52-57 
(Appendix 1)   
6-60 
months 
€1,000-
€12,000 
+ No official cost for 
filing observations 
- No possibility to 
appeal the decision 
- Observer can not 
participate in the 
examination, appeal 
of opposition 
proceedings 
Revocation 
action   X X X 
Any time after the 
patent has been 
granted 
National 
courts 
Appeal to 
national 
courts 
Grounds for the 
actions are 
defined in EPC 
Article 138 
(Appendix 6) 
Each jurisdiction 
can make a 
different ruling 
Germany: 
12-18 
months 
France: 
16-25 
months 
UK: 9-14 
months 
Germany: 
€45,000-
€110,000 
France: 
€80,000-
€200,000 
UK: 
£350,000-
£1,000,000 
+ Same court will 
decide both 
infringement and 
invalidity of the 
patent in United 
Kingdom and France 
- Same court will not 
decide both 
infringement and 
invalidity of the 
patent in Germany 
- Judges making the 
decision are not 
necessarily technical 
experts 
- Huge costs 
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Table 6. Defensive methods available for European patents 
   T     i m     i n     g          
Methods for 
European 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion Additional Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of the 
procee-
ding 
Advantages / 
Disadvantages 
Compulso-
ry licenses   X X X 
After a reasonable 
time has passed 
since the grant of 
the patent 
National 
courts 
Appeal to 
national 
courts 
Grounds vary in 
different 
countries.  
License fee will 
be mandatory if 
compulsory 
license is granted 
Same as 
for 
revocation 
Same as 
for 
revocation 
- Limited number of 
requests made and 
limited number of 
compulsory licenses 
granted 
- License fee will be 
mandatory if 
compulsory license is 
granted 
Patent 
exhaustion   X   X 
Method brought 
usually in case of 
infringement 
proceedings 
National 
courts 
Appeal to 
national 
courts 
Grounds: 
patentee has no 
rights to oppose 
the free 
circulation of 
goods that 
infringe his 
patent once the 
products have 
been put to 
market (=inside 
EU) with patent 
owners consent 
Community-wide 
exhaustion 
available in each 
EU country 
Same as 
for 
revocation 
Same as 
for 
revocation 
+ Risk free defense 
method 
- Limited 
applicability 
(resellers and 
importers) 
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Table 7. Defensive methods available for European patents 
   T    i m     i n     g          
Methods for 
European 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion Additional Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of the 
procee-
ding 
Advantages / 
Disadvantages 
Prior use   X   X 
Method brought 
usually in case of 
infringement 
proceedings 
National 
courts 
Appeal 
to 
national 
courts 
Grounds vary in 
different countries.  
Possible 
limitations for 
the right of use 
based on 
country 
legislation 
Same as 
for 
revocation 
Same as 
for 
revocation 
- Use of invention 
can be limited, 
based on country's 
legislation 
Declaration 
of non-
infringement   X X X 
Method brought 
usually in case of 
infringement 
proceedings 
National 
courts 
Appeal 
to 
national 
courts 
Grounds for the 
actions are that the 
applicant has 
applied an 
acknowledgement 
for declaration of 
non-infringement 
and the proprietor 
has refused to give 
it. 
Available in UK 
and France. 
Same as 
for 
revocation 
Same as 
for 
revocation 
+ Possibility to use 
declaration of non-
infringement 
applied in one 
country to stay 
infringement 
proceedings in 
another country 
- Can only be 
applied to products 
and processes as 
they were 
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Table 8. Defensive methods available for the United States patents 
   T     i m     i n     g          
Methods 
for US 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of 
the 
procee-
ding 
Advantages / 
Disadvantages 
Ex parte 
reexami-
nation   X X X   USPTO No 
Grounds are lack of 
novelty or obviousness 
Only 
printed 
publications 
and patents 
can be used 
as prior art 
<24 
months <$50,000 
+ USPTO has technical 
experts to study the case 
- Requestor not entitled 
to participate the 
examination procedure 
- Requestor not entitled 
to appeal the decision 
Inter 
partes 
reexami-
nation   X X X   USPTO 
Appeal to 
board of 
Appeals and 
Interferences 
Grounds are lack of 
novelty or obviousness 
Only 
printed 
publications 
and patents 
can be used 
as prior art 
<24 
months <$200,000 
+ USPTO has technical 
experts to study the case 
+ Requestor entitled to 
participate the 
examination procedure 
+ Requestor entitled to 
appeal the decision 
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Table 9. Defensive methods available for the United States patents 
   T     i m     i n     g          
Methods for 
US patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of the 
proceeding 
Advantages / 
Disadvantages 
Interfe-
rence X X X X 
Requestor's own 
patent 
application must 
be filed  
1) within one 
year of the grant 
of the third party 
patent or  
2) within one 
year of the 
publication of 
the third party 
application 
USPTO 
BAI 
Appeal 
to 
Federal 
Circuit 
Requestor must have a 
pending application 
claiming same subject 
matter.   
12 
months <$1,000,000 
+ USPTO has technical 
experts to study the case 
+ Results received 
relatively shortly 
- Proceeding can 
jeopardize the requestor's 
own patent 
Invalida-
tion via 
court   X X X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds are defined in 
USC 101 (Appendix 8), 
USC 102 (Appendix 9), 
USC 103 (Appendix 10), 
USC 112 (Appendix 12), 
or USC 251 (Appendix 
13)   
24-36 
months 
$1,000,000-
$25,000,000 
+ Scope of claims will be 
construed the same 
whether the purpose is to 
analyse infringement or 
validity 
- Judges making the 
decision are not 
necessarily technical 
experts 
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Table 10. Defensive methods available for the United States patents 
   T     i m     i n     g          
Methods 
for US 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration of 
the procee-
ding 
Cost of the 
proceeding 
Advantages / 
Disadvantages 
Antitrust   X (X) X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds are defined in 
Sherman Antitrust Act 
(Appendix 14)   
Same as for 
invalidation 
via court 
Same as for 
invalidation 
via court 
- Rarely a viable defense 
method 
Patent 
misuse   X   X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds are that the 
patentee has 
impermissibly broadened 
the scope of the granted 
patent with 
anticompetitive effect   
Same as for 
invalidation 
via court 
Same as for 
invalidation 
via court 
+ More convenient to 
claim than antitrust 
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Table 11. Defensive methods available for the United States patents 
   T     i m     i n     g          
Methods for 
US patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration of 
the procee-
ding 
Cost of the 
proceeding 
Advantages / 
Disadvantages 
Patent 
exhaustion   X   X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds: patentee has no 
rights to oppose the free 
circulation of goods that 
infringe his patent once 
the products have been 
put to market (=inside the 
U.S.) with patent owners 
consent   
Same as for 
invalidation 
via court 
Same as for 
invalidation 
via court 
+ Risk free defense 
method 
- Limited applicability 
(resellers) 
Inequitable 
conduct   X   X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds are that the 
patentee has intended to 
deceive the patent 
examiner by not 
disclosing all relevant 
information to him/her    
Same as for 
invalidation 
via court 
Same as for 
invalidation 
via court 
- Hard to find evidence 
and to proof the 
inequitable conduct 
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Table 12. Defensive methods available for the United States patents 
   T     i m     i n     g          
Methods 
for US 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration of 
the procee-
ding 
Cost of the 
proceeding 
Advantages / 
Disadvantages 
Laches   X   X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds are following: 
1) Unreasonable and 
inexcusable delay by the 
plaintiff in bringing the 
patent infringement suit; 
and 
2) The defendant was 
materially prejudiced due 
to the plaintiff’s delay   
Same as for 
invalidation 
via court 
Same as for 
invalidation 
via court 
- Can only be used to 
stop recovery of damages 
relating to patent 
infringement occurring 
prior to the filing of the 
infringement suit 
Equitable 
estoppel   X   X   
District 
Court / 
ITC 
Appeal 
to 
Federal 
Circuit 
Grounds are following:  
1. The plaintiff misleads 
the defendant into 
reasonably inferring that 
the plaintiff does not 
intend to enforce its 
patents against the 
defendant, and  
2. the defendant relies on 
the plaintiff’s misleading 
conduct, and  
3. due to its reliance, the 
defendant will be 
materially prejudiced if 
the plaintiff is allowed to 
proceed with its 
infringement claim   
Same as for 
invalidation 
via court 
Same as for 
invalidation 
via court 
+ Can be used to  block 
the infringement action 
completely 
 
 
65
   
Table 13. Defensive methods available for Chinese patents 
   T     i m     i n     g          
Methods for 
Chinese 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of 
the 
procee-
ding 
Advantages / 
Disadvantages 
Invalidation   X X X 
Anytime 
after the 
grant of the 
patent 
SIPO Patent 
Re-
examination 
Board 
Appeal 
to 
People's 
Court 
Grounds are following: 
1) Substantive grounds:  non-
patentable subject matter, 
lack of novelty, 
inventiveness or practical 
utility. 
2) Technical grounds:  added 
subject matter, insufficient 
disclosure of description, 
claim lacking support, claim 
lacking clarity and/or 
succinctness, double 
claiming, proceedings   
6-36 
months 
$15,000-
$25,000 
+ The patentee has 
very limited flexibility 
to amend the claims 
- Decision will not 
have retroactive effect 
on judgements made 
on patent 
infringement 
IP abuse and 
antimonopoly 
issues   X (X) X 
Defense for 
infringement 
Intermediate 
Court 
Appeal 
to High 
Court 
Grounds are following: 
1) Anticompetitive 
agreements made by the third 
party, or 
2) Abuse of dominant market 
or 
3) Patent misuse   
6-18 
months 
$50,000-
$150,000 
+ Can be strong 
defense against 
multinational 
companies 
+ May stay 
infringement 
proceedings 
- Relevant law came 
into effect only a year 
ago 
 
 
 
66
   
Table 14. Defensive methods available for Chinese patents 
   T     i m     i n     g          
Methods for 
Chinese 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of 
the 
procee-
ding 
Advantages / 
Disadvantages 
Compulsory 
licenses   X X X 
After a 
reasonable 
time has 
passed since 
the grant of 
the patent SIPO   
Appeal 
to High 
Court 
Grounds are following: 
1) Requestor has been unable 
to obtain a license on 
reasonable terms within 
reasonable period of time, or 
2) patent owned by requestor 
is technically more advanced 
than another earlier filed 
patented invention and the 
exploitation of their own 
patent is dependent on 
exploitation of the earlier 
filed patent 
 License 
fee will be 
mandatory 
if 
compulsory 
license is 
granted 
6-18 
months 
$50,000-
$150,000 
- Limited number of 
requests made and 
limited number of 
compulsory licenses 
granted 
- License fee will be 
mandatory if 
compulsory license is 
granted 
Prior use   X   X 
Defense for 
infringement 
Intermediate 
Court 
Appeal 
to High 
Court 
Grounds are the following: 
The requestor has made 
necessary preparations for 
making and using the 
patented invention in China 
before the priority date of the 
patent   
6-18 
months 
$50,000-
$150,000 
- Use of invention can 
be limited, based on 
country's legislation 
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Table 15. Defensive methods available for Chinese patents 
   T     i m     i n     g          
Methods for 
Chinese 
patents 
Pen-
ding 
Appli-
cation 
Gran-
ted 
patent 
Before 
in 
litiga-
tion 
During 
litiga-
tion 
Additional 
Criteria Venue Appeal Prerequisites 
Additional 
information 
Duration 
of the 
procee-
ding 
Cost of 
the 
procee-
ding 
Advantages / 
Disadvantages 
Patent 
exhaustion   X   X   
Intermediate 
Court 
Appeal 
to High 
Court 
Grounds: patentee has no rights 
to oppose the free circulation 
of goods that infringe his 
patent once the products have 
been put to market anywhere in 
the world with patent owners 
consent   
6-18 
months 
$50,000-
$150,000 
+ Risk free defense 
method 
- Limited applicability 
(resellers and 
importers) 
Declaration 
of non-
infringement   X X X   
Intermediate 
Court 
Appeal 
to High 
Court 
Grounds are following:  
1) Requestor has asked for 
acknowledgement for 
declaration of non-
infringement and the proprietor 
has refused to give it, or 
2) The patentee has sent 
warning letters and accused of 
patent infringement   
6-18 
months 
$50,000-
$150,000 
+ If filed before 
infringement litigation, 
the same court selected 
by the defendant will 
handle also the 
infringement 
+ Grounds for filing 
are low 
- Can only be applied 
to products and 
processes as they were 
 
 
 
68
 69  
4.2. Assessment of the study 
The aim of the study was to identify defensive methods against third party patents and 
to discover the dependency between intellectual property strategy and the likelihood of 
patent disputes. This chapter will assess how these questions were answered and how 
reliable the conclusions are. 
The first research question about the dependency between intellectual property strategy 
and the likelihood of patent disputes was answered at the end of chapter 3.1, making it a 
natural step to move on to discuss the available methods. The available methods and 
their prerequisites where then revealed in chapters 3.4, 3.7 and 3.10. Finally, the chapter 
3.11 presents the last research question by identifying the advantages and disadvantages 
of the methods. 
When assessing the study, the collected and used material plays a critical role. The 
source material for the study was gathered from libraries, such as the Tampere 
University of Technology library, the University of Tampere library and the Tampere 
city library. Some of the material was also readily available via colleagues at Nokia 
Corporation. The best source for most up-to-date information was for example the 
national patent offices and various journals available via the electronic library at 
Tampere University of Technology. A lot of information was available so that context 
was easy to build.  
Reliability for the study was ascertained by considering which source materials would 
be used, and by double-checking arguments from various different sources. The national 
patent offices usually have the most up-to-date information regarding the available 
procedures they provide, and they can be considered as a reliable source. Also, the 
national law can be considered to be a reliable source. However, it can be quite 
challenging to interpret the national laws and the rules of national patent offices. 
Therefore, the various journals and books come as a handy tool. They can provide the 
needed interpretation and the information they provide can always be double-checked 
from the national laws and rules. When the national laws and rules of the local patent 
offices were written in some other language than English, the reliability of the 
information was validated by analyzing several independent sources. Also, the 
presented legal and procedural facts were reviewed by experts working on those fields. 
Some of the gathered information, such as the average costs and duration of the 
proceedings, were not always available from the journals or books, so in those cases the 
information was gathered from people working with the issues, which therefore 
represent the subjective views of the individuals. 
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Issues that affect the available defensive methods are national and regional laws and 
rules, which of course change over time. Therefore, especially the rapidly changing 
intellectual property legislation and environment in China set some challenges to the 
study. Needless to say that the language issues set some challenges as well, but all in all 
there was a surprisingly lot of source material available in English as well. It is, 
however, relevant to raise some criticism here by stating that relying on second hand 
information is never as reliable as going directly to the source, irrespective of the 
language.  
In the common law countries the precedents played a critical role on how to interpret 
the law and as time goes by, new precedents will replace the old ones affecting the 
available methods. Therefore it is critical to update the study based on new precedents 
and changes in laws and rules, if it will be used as a guideline for determining which 
methods to use. 
The reliability of the study can also be assessed by determining if another researcher 
would came up with the same results as presented in this study. The conceptual 
approach for identifying the relationship between the intellectual property strategy and 
the likelihood of patent disputes is based on one viewpoint on how the strategy can be 
described. There can very well be other approaches and viewpoints on how the 
intellectual property strategy is seen, but regardless of them, if the intellectual property 
strategy is split into actions, the conclusion about the likelihood will remain the same.  
The conceptual approach for identifying various methods available is based on hard 
facts and any researcher would very likely come to the same conclusions. The 
somewhat hermeneutic approach on analysis the advantages and disadvantages of the 
various methods makes it a bit more difficult, if not possible, to find out their 
repeatability, as in hermeneutics approach the results include a lot of interpretations of 
the researcher. This is one of the reasons why the study is unable to give forthright 
recommendations based on hard facts what method is the best choice. However, many 
of the advantages and disadvantages are based on the information sources used to 
identify the various methods. 
All in all, this study has been quite useful for gaining a deeper understanding on the 
various factors affecting the likelihood of patent disputes and by providing practical 
tools for tackling any third party patents in various situations. However, it should be 
noticed that the use of any defensive method should be investigated case by case in 
order to determine its effect on the efficient resolution of a patent dispute. Furthermore, 
even if the study concentrated specifically on patents it should be noted that many of the 
defensive methods presented are usable also for utility models. 
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4.3. Recommendations for further study  
The challenge in a study like this is that the analysis can never be exhaustive. As the 
laws change and the precedents change the way how the laws are interpreted it would be 
critical to update the study as well. Furthermore, in common law countries the depth of 
the analysis could go much deeper by identifying how the laws are interpreted in 
various situations. But many obstacles always remain, because the usable methods vary 
based on (1) the patent in question, (2) the market situation, (3) the conducts of the 
patentee, (4) the accused product or process, and many more variables.  
The study could also be broadened by analyzing more countries, as they would probably 
affect also to the observed advantages and disadvantages of the current methods listed. 
Furthermore, if language is not an issue the Chinese, French and German literature 
could bring more value to the study. 
If a more empirical approach should be chosen, the methods and their possible synergies 
could be studied in a more concrete way. But the sample size in such case should be 
significant to demonstrate when the selected methods work and when they don’t work.  
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APPENDIX 1: EPC Articles 52-57 Patentability 
 
 
Article 52 
Patentable inventions 
 
(1) European patents shall be granted for any inventions, in all fields of technology, 
provided that they are new, involve an inventive step and are susceptible of industrial 
application. 
 
(2) The following in particular shall not be regarded as inventions within the meaning of 
paragraph 1: 
 
(a) discoveries, scientific theories and mathematical methods; 
 
(b) aesthetic creations; 
 
(c) schemes, rules and methods for performing mental acts, playing games or doing 
business, and programs for computers; 
 
(d) presentations of information. 
 
(3) Paragraph 2 shall exclude the patentability of the subject-matter or activities referred 
to therein only to the extent to which a European patent application or 
European patent relates to such subject-matter or activities as such. 
 
 
Article 53 
Exceptions to patentability 
 
European patents shall not be granted in respect of: 
 
(a) inventions the commercial exploitation of which would be contrary to "ordre public" 
or morality; such exploitation shall not be deemed to be so contrary 
merely because it is prohibited by law or regulation in some or all of the Contracting 
States; 
 
(b) plant or animal varieties or essentially biological processes for the production of 
plants or animals; this provision shall not apply to microbiological processes or the 
products thereof; 
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(c) methods for treatment of the human or animal body by surgery or therapy and 
diagnostic methods practised on the human or animal body; this provision 
shall not apply to products, in particular substances or compositions, for use in any of 
these methods. 
 
 
Article 54 
Novelty 
 
(1) An invention shall be considered to be new if it does not form part of the state of the 
art. 
 
(2) The state of the art shall be held to comprise everything made available to the public 
by means of a written or oral description, by use, or in any other 
way, before the date of filing of the European patent application. 
 
(3) Additionally, the content of European patent applications as filed, the dates of filing 
of which are prior to the date referred to in paragraph 2 and which 
were published on or after that date, shall be considered as comprised in the state of the 
art. 
 
(4) Paragraphs 2 and 3 shall not exclude the patentability of any substance or 
composition, comprised in the state of the art, for use in a method 
referred to in Article 53(c), provided that its use for any such method is not comprised 
in the state of the art. 
 
(5) Paragraphs 2 and 3 shall also not exclude the patentability of any substance or 
composition referred to in paragraph 4 for any specific use in a method referred to in 
Article 53(c), provided that such use is not comprised in the state of the art. 
 
 
Article 55 
Non-prejudicial disclosures 
 
(1) For the application of Article 54, a disclosure of the invention shall not be taken into 
consideration if it occurred no earlier than six months preceding the filing of the 
European patent application and if it was due to, or in consequence of: 
 
(a)43 an evident abuse in relation to the applicant or his legal predecessor, or 
 
(b) the fact that the applicant or his legal predecessor has displayed the invention at an 
official, or officially recognised, international exhibition falling within the terms of the 
APPENDIX 1 (3/3) 
Convention on international exhibitions signed at Paris on 22 November 1928 and last 
revised on 30 November 1972. 
 
(2) In the case of paragraph 1(b), paragraph 1 shall apply only if the applicant states, 
when filing the European patent application, that the invention has been so displayed 
and files a supporting certificate within the time limit and under the conditions laid 
down in the Implementing Regulations. 
 
 
 
 
Article 56 
Inventive step 
 
An invention shall be considered as involving an inventive step if, having regard to the 
state of the art, it is not obvious to a person skilled in the art. If the 
state of the art also includes documents within the meaning of Article 54, paragraph 3, 
these documents shall not be considered in deciding whether there has been an inventive 
step. 
 
 
Article 57 
Industrial application 
 
An invention shall be considered as susceptible of industrial application if it can be 
made or used in any kind of industry, including agriculture. 
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APPENDIX 2: EPC Article 100 Grounds for opposition 
 
 
Article 100 
Grounds for opposition 
 
Opposition may only be filed on the grounds that: 
 
(a) the subject-matter of the European patent is not patentable under Articles 52 to 57; 
 
(b) the European patent does not disclose the invention in a manner sufficiently clear 
and complete for it to be carried out by a person skilled in the art;  
 
(c) the subject-matter of the European patent extends beyond the content of the 
application as filed, or, if the patent was granted on a divisional application or on a new 
application filed under Article 61, beyond the content of the earlier application as filed. 
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APPENDIX 3: EPC Article 61 European patent applications filed by non-entitled 
persons 
 
 
 
Article 61 
European patent applications filed by non-entitled persons 
 
(1) If by a final decision it is adjudged that a person other than the applicant is entitled 
to the grant of the European patent, that person may, in accordance with the 
Implementing Regulations: 
 
(a) prosecute the European patent application as his own application in place of the 
applicant; 
 
(b) file a new European patent application in respect of the same invention; or 
 
(c) request that the European patent application be refused. 
 
(2) Article 76, paragraph 1, shall apply mutatis mutandis to a new European patent 
application filed under paragraph 1(b). 
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APPENDIX 4: EPC Article 105 Intervention of the assumed infringer 
 
 
 
Article 105 
Intervention of the assumed infringer 
 
(1) Any third party may, in accordance with the Implementing Regulations, intervene in 
opposition proceedings after the opposition period has expired, if 
the third party proves that 
 
(a) proceedings for infringement of the same patent have been instituted against him, or 
 
(b) following a request of the proprietor of the patent to cease alleged infringement, the 
third party has instituted proceedings for a ruling that he is not 
infringing the patent. 
 
(2) An admissible intervention shall be treated as an opposition. 
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APPENDIX 5: EPC Article 115 Observations by third parties 
 
 
Article 115 
Observations by third parties 
 
In proceedings before the European Patent Office, following the publication of the 
European patent application, any third party may, in accordance with the Implementing 
Regulations, present observations concerning the patentability of the invention to which 
the application or patent relates. That person shall not be a party to the proceedings. 
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APPENDIX 6: EPC Article 138 Revocation of European patents 
 
 
 
Article 138 
Revocation of European patents 
 
(1) Subject to Article 139, a European patent may be revoked with effect for a 
Contracting State only on the grounds that: 
 
(a) the subject-matter of the European patent is not patentable under Articles 52 to 57; 
 
(b) the European patent does not disclose the invention in a manner sufficiently clear 
and complete for it to be carried out by a person skilled in the art; 
 
(c)150the subject-matter of the European patent extends beyond the content of the 
application as filed or, if the patent was granted on a divisional application or on a new 
application filed under Article 61, beyond the content of the earlier 
application as filed; 
 
(d) the protection conferred by the European patent has been extended; or 
 
(e) the proprietor of the European patent is not entitled under Article 60, paragraph 1. 
 
(2) If the grounds for revocation affect the European patent only in part, the patent shall 
be limited by a corresponding amendment of the claims and revoked in part. 
 
(3) In proceedings before the competent court or authority relating to the validity of the 
European patent, the proprietor of the patent shall have the right to limit the patent by 
amending the claims. The patent as thus limited shall form the basis for the proceedings. 
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APPENDIX 7: EPC Article 60 Right to European patent 
 
 
 
Article 60 
Right to a European patent 
 
(1) The right to a European patent shall belong to the inventor or his successor in title. If 
the inventor is an employee, the right to a European patent shall be determined in 
accordance with the law of the State in which the employee is mainly employed; if the 
State in which the employee is mainly employed cannot be determined, the law to be 
applied shall be that of the State in which the employer has the place of business to 
which the employee is attached. 
 
(2) If two or more persons have made an invention independently of each other, the 
right to a European patent therefor shall belong to the person whose European patent 
application has the earliest date of filing, provided that this first application has been 
published. 
 
(3) In proceedings before the European Patent Office, the applicant shall be deemed to 
be entitled to exercise the right to a European patent. 
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APPENDIX 8: United Kingdom Patent Act 1977, Chapter 37 section 71 
 
 
Declaration or declarator as to non-infringement 
71.-  
(1) Without prejudice to the court's jurisdiction to make a declaration or declarator 
apart from this section, a declaration or declarator that an act does not, or a proposed 
act would not, constitute an infringement of a patent may be made by the court or 
the comptroller in proceedings between the person doing or proposing to do the act 
and the proprietor of the patent, not withstanding that no assertion to the contrary 
has been made by the proprietor, if it is shown-  
(a) that that person has applied in writing to the proprietor for a written 
acknowledgment to the effect of the declaration or declarator claimed, and has 
furnished him with full particulars in writing of the act in question; and  
(b) that the proprietor has refused or failed to give any such acknowledgment.  
(2) Subject to section 72(5) below, a declaration made by the comptroller under this 
section shall have the same effect as a declaration or declarator by the court.  
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APPENDIX 9: USC Section 101 of title 35: Inventions patentable 
 
 
Inventions patentable 
 
Whoever invents or discovers any new and useful process, machine, manufacture, or 
composition of matter, or any new and useful improvement thereof, may obtain a patent 
therefor, subject to the conditions and requirements of this title.  
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APPENDIX 10: USC Section 102 of title 35: Conditions for patentability 
 
 
Conditions for patentability; novelty and loss of right to patent 
 
A person shall be entitled to a patent unless—  
(a) the invention was known or used by others in this country, or patented or 
described in a printed publication in this or a foreign country, before the 
invention thereof by the applicant for patent, or  
(b) the invention was patented or described in a printed publication in this or a 
foreign country or in public use or on sale in this country, more than one year 
prior to the date of the application for patent in the United States, or  
(c) he has abandoned the invention, or  
(d) the invention was first patented or caused to be patented, or was the subject of an 
inventor’s certificate, by the applicant or his legal representatives or assigns in a 
foreign country prior to the date of the application for patent in this country on 
an application for patent or inventor’s certificate filed more than twelve months 
before the filing of the application in the United States, or  
(e) the invention was described in  
(1) an application for patent, published under section 122 (b), by another filed in 
the United States before the invention by the applicant for patent or  
(2) a patent granted on an application for patent by another filed in the United 
States before the invention by the applicant for patent, except that an 
international application filed under the treaty defined in section 351 (a) shall 
have the effects for the purposes of this subsection of an application filed in the 
United States only if the international application designated the United States 
and was published under Article 21(2) of such treaty in the English language; or  
(f) he did not himself invent the subject matter sought to be patented, or  
(g)  
(1) during the course of an interference conducted under section 135 or section 
291, another inventor involved therein establishes, to the extent permitted in 
section 104, that before such person’s invention thereof the invention was made 
by such other inventor and not abandoned, suppressed, or concealed, or  
(2) before such person’s invention thereof, the invention was made in this 
country by another inventor who had not abandoned, suppressed, or concealed 
it. In determining priority of invention under this subsection, there shall be 
considered not only the respective dates of conception and reduction to practice 
of the invention, but also the reasonable diligence of one who was first to 
conceive and last to reduce to practice, from a time prior to conception by the 
other.  
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APPENDIX 11: USC Section 103 of title 35: Conditions for patentability 
 
 
Conditions for patentability; non-obvious subject matter 
 
(a) A patent may not be obtained though the invention is not identically disclosed or 
described as set forth in section 102 of this title, if the differences between the subject 
matter sought to be patented and the prior art are such that the subject matter as a whole 
would have been obvious at the time the invention was made to a person having 
ordinary skill in the art to which said subject matter pertains. Patentability shall not be 
negatived by the manner in which the invention was made.  
 
(b)  
(1) Notwithstanding subsection (a), and upon timely election by the applicant for 
patent to proceed under this subsection, a biotechnological process using or 
resulting in a composition of matter that is novel under section 102 and nonobvious 
under subsection (a) of this section shall be considered nonobvious if—  
(A) claims to the process and the composition of matter are contained in either 
the same application for patent or in separate applications having the same 
effective filing date; and  
(B) the composition of matter, and the process at the time it was invented, were 
owned by the same person or subject to an obligation of assignment to the same 
person.  
(2) A patent issued on a process under paragraph (1)—  
(A) shall also contain the claims to the composition of matter used in or made 
by that process, or  
(B) shall, if such composition of matter is claimed in another patent, be set to 
expire on the same date as such other patent, notwithstanding section 154.  
(3) For purposes of paragraph (1), the term “biotechnological process” means—  
(A) a process of genetically altering or otherwise inducing a single- or multi-
celled organism to—  
(i) express an exogenous nucleotide sequence,  
(ii) inhibit, eliminate, augment, or alter expression of an endogenous 
nucleotide sequence, or  
(iii) express a specific physiological characteristic not naturally associated 
with said organism;  
(B) cell fusion procedures yielding a cell line that expresses a specific protein, 
such as a monoclonal antibody; and  
(C) a method of using a product produced by a process defined by subparagraph 
(A) or (B), or a combination of subparagraphs (A) and (B).  
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(c)  
(1) Subject matter developed by another person, which qualifies as prior art only 
under one or more of subsections (e), (f), and (g) of section 102 of this title, shall 
not preclude patentability under this section where the subject matter and the 
claimed invention were, at the time the claimed invention was made, owned by the 
same person or subject to an obligation of assignment to the same person.  
(2) For purposes of this subsection, subject matter developed by another person and 
a claimed invention shall be deemed to have been owned by the same person or 
subject to an obligation of assignment to the same person if—  
(A) the claimed invention was made by or on behalf of parties to a joint research 
agreement that was in effect on or before the date the claimed invention was 
made;  
(B) the claimed invention was made as a result of activities undertaken within 
the scope of the joint research agreement; and  
(C) the application for patent for the claimed invention discloses or is amended 
to disclose the names of the parties to the joint research agreement.  
(3) For purposes of paragraph (2), the term “joint research agreement” means a 
written contract, grant, or cooperative agreement entered into by two or more 
persons or entities for the performance of experimental, developmental, or research 
work in the field of the claimed invention.  
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APPENDIX 12: USC Section 271 of title 35: Infringement of patent 
 
 
Infringement of patent 
 
(a) Except as otherwise provided in this title, whoever without authority makes, uses, 
offers to sell, or sells any patented invention, within the United States or imports into 
the United States any patented invention during the term of the patent therefor, infringes 
the patent.  
 
(b) Whoever actively induces infringement of a patent shall be liable as an infringer.  
 
(c) Whoever offers to sell or sells within the United States or imports into the United 
States a component of a patented machine, manufacture, combination or composition, or 
a material or apparatus for use in practicing a patented process, constituting a material 
part of the invention, knowing the same to be especially made or especially adapted for 
use in an infringement of such patent, and not a staple article or commodity of 
commerce suitable for substantial noninfringing use, shall be liable as a contributory 
infringer.  
 
(d) No patent owner otherwise entitled to relief for infringement or contributory 
infringement of a patent shall be denied relief or deemed guilty of misuse or illegal 
extension of the patent right by reason of his having done one or more of the following:  
(1) derived revenue from acts which if performed by another without his consent 
would constitute contributory infringement of the patent;  
(2) licensed or authorized another to perform acts which if performed without his 
consent would constitute contributory infringement of the patent;  
(3) sought to enforce his patent rights against infringement or contributory 
infringement;  
(4) refused to license or use any rights to the patent; or  
(5) conditioned the license of any rights to the patent or the sale of the patented 
product on the acquisition of a license to rights in another patent or purchase of a 
separate product, unless, in view of the circumstances, the patent owner has market 
power in the relevant market for the patent or patented product on which the license 
or sale is conditioned.  
 
(e)  
(1) It shall not be an act of infringement to make, use, offer to sell, or sell within the 
United States or import into the United States a patented invention (other than a new 
animal drug or veterinary biological product (as those terms are used in the Federal 
Food, Drug, and Cosmetic Act and the Act of March 4, 1913) which is primarily 
manufactured using recombinant DNA, recombinant RNA, hybridoma technology, 
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or other processes involving site specific genetic manipulation techniques) solely 
for uses reasonably related to the development and submission of information under 
a Federal law which regulates the manufacture, use, or sale of drugs or veterinary 
biological products.  
(2) It shall be an act of infringement to submit—  
(A) an application under section 505(j) of the Federal Food, Drug, and 
Cosmetic Act or described in section 505(b)(2) of such Act for a drug claimed 
in a patent or the use of which is claimed in a patent, or  
(B) an application under section 512 of such Act or under the Act of March 4, 
1913 (21 U.S.C. 151–158) for a drug or veterinary biological product which is 
not primarily manufactured using recombinant DNA, recombinant RNA, 
hybridoma technology, or other processes involving site specific genetic 
manipulation techniques and which is claimed in a patent or the use of which 
is claimed in a patent,  
if the purpose of such submission is to obtain approval under such Act to engage in the 
commercial manufacture, use, or sale of a drug or veterinary biological product claimed 
in a patent or the use of which is claimed in a patent before the expiration of such 
patent.  
(3) In any action for patent infringement brought under this section, no injunctive or 
other relief may be granted which would prohibit the making, using, offering to sell, 
or selling within the United States or importing into the United States of a patented 
invention under paragraph (1).  
(4) For an act of infringement described in paragraph (2)—  
(A) the court shall order the effective date of any approval of the drug or 
veterinary biological product involved in the infringement to be a date which 
is not earlier than the date of the expiration of the patent which has been 
infringed,  
(B) injunctive relief may be granted against an infringer to prevent the 
commercial manufacture, use, offer to sell, or sale within the United States or 
importation into the United States of an approved drug or veterinary biological 
product, and  
(C) damages or other monetary relief may be awarded against an infringer 
only if there has been commercial manufacture, use, offer to sell, or sale 
within the United States or importation into the United States of an approved 
drug or veterinary biological product.  
The remedies prescribed by subparagraphs (A), (B), and (C) are the only remedies 
which may be granted by a court for an act of infringement described in paragraph (2), 
except that a court may award attorney fees under section 285.  
(5) Where a person has filed an application described in paragraph (2) that includes 
a certification under subsection (b)(2)(A)(iv) or (j)(2)(A)(vii)(IV) of section 505 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355), and neither the owner 
of the patent that is the subject of the certification nor the holder of the approved 
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application under subsection (b) of such section for the drug that is claimed by the 
patent or a use of which is claimed by the patent brought an action for infringement 
of such patent before the expiration of 45 days after the date on which the notice 
given under subsection (b)(3) or (j)(2)(B) of such section was received, the courts of 
the United States shall, to the extent consistent with the Constitution, have subject 
matter jurisdiction in any action brought by such person under section 2201 of title 
28 for a declaratory judgment that such patent is invalid or not infringed.  
 
(f)  
(1) Whoever without authority supplies or causes to be supplied in or from the 
United States all or a substantial portion of the components of a patented invention, 
where such components are uncombined in whole or in part, in such manner as to 
actively induce the combination of such components outside of the United States in 
a manner that would infringe the patent if such combination occurred within the 
United States, shall be liable as an infringer.  
(2) Whoever without authority supplies or causes to be supplied in or from the 
United States any component of a patented invention that is especially made or 
especially adapted for use in the invention and not a staple article or commodity of 
commerce suitable for substantial noninfringing use, where such component is 
uncombined in whole or in part, knowing that such component is so made or 
adapted and intending that such component will be combined outside of the United 
States in a manner that would infringe the patent if such combination occurred 
within the United States, shall be liable as an infringer.  
 
(g) Whoever without authority imports into the United States or offers to sell, sells, or 
uses within the United States a product which is made by a process patented in the 
United States shall be liable as an infringer, if the importation, offer to sell, sale, or use 
of the product occurs during the term of such process patent. In an action for 
infringement of a process patent, no remedy may be granted for infringement on 
account of the noncommercial use or retail sale of a product unless there is no adequate 
remedy under this title for infringement on account of the importation or other use, offer 
to sell, or sale of that product. A product which is made by a patented process will, for 
purposes of this title, not be considered to be so made after—  
(1) it is materially changed by subsequent processes; or  
(2) it becomes a trivial and nonessential component of another product.  
 
(h) As used in this section, the term “whoever” includes any State, any instrumentality 
of a State, and any officer or employee of a State or instrumentality of a State acting in 
his official capacity. Any State, and any such instrumentality, officer, or employee, shall 
be subject to the provisions of this title in the same manner and to the same extent as 
any nongovernmental entity.  
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(i) As used in this section, an “offer for sale” or an “offer to sell” by a person other than 
the patentee, or any designee of the patentee, is that in which the sale will occur before 
the expiration of the term of the patent.  
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APPENDIX 13: USC Section 1337 of Title 19: Unfair practices in import trade 
 
 
Unfair practices in import trade 
 
(a) Unlawful activities; covered industries; definitions  
(1) Subject to paragraph (2), the following are unlawful, and when found by the 
Commission to exist shall be dealt with, in addition to any other provision of law, as 
provided in this section:  
(A) Unfair methods of competition and unfair acts in the importation of articles 
(other than articles provided for in subparagraphs (B), (C), (D), and (E)) into the 
United States, or in the sale of such articles by the owner, importer, or 
consignee, the threat or effect of which is—  
(i) to destroy or substantially injure an industry in the United States;  
(ii) to prevent the establishment of such an industry; or  
(iii) to restrain or monopolize trade and commerce in the United States.  
(B) The importation into the United States, the sale for importation, or the sale 
within the United States after importation by the owner, importer, or consignee, 
of articles that—  
(i) infringe a valid and enforceable United States patent or a valid and 
enforceable United States copyright registered under title 17; or  
(ii) are made, produced, processed, or mined under, or by means of, a 
process covered by the claims of a valid and enforceable United States 
patent.  
(C) The importation into the United States, the sale for importation, or the sale 
within the United States after importation by the owner, importer, or consignee, 
of articles that infringe a valid and enforceable United States trademark 
registered under the Trademark Act of 1946 [15 U.S.C. 1051 et seq.].  
(D) The importation into the United States, the sale for importation, or the sale 
within the United States after importation by the owner, importer, or consignee, 
of a semiconductor chip product in a manner that constitutes infringement of a 
mask work registered under chapter 9 of title 17.  
(E) The importation into the United States, the sale for importation, or the sale 
within the United States after importation by the owner, importer, or consigner, 
of an article that constitutes infringement of the exclusive rights in a design 
protected under chapter 13 of title 17.  
(2) Subparagraphs (B), (C), (D), and (E) of paragraph (1) apply only if an industry 
in the United States, relating to the articles protected by the patent, copyright, 
trademark, mask work, or design concerned, exists or is in the process of being 
established.  
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(3) For purposes of paragraph (2), an industry in the United States shall be 
considered to exist if there is in the United States, with respect to the articles 
protected by the patent, copyright, trademark, mask work, or design concerned—  
(A) significant investment in plant and equipment;  
(B) significant employment of labor or capital; or  
(C) substantial investment in its exploitation, including engineering, research 
and development, or licensing.  
(4) For the purposes of this section, the phrase “owner, importer, or consignee” 
includes any agent of the owner, importer, or consignee.  
 
(b) Investigation of violations by Commission  
(1) The Commission shall investigate any alleged violation of this section on 
complaint under oath or upon its initiative. Upon commencing any such 
investigation, the Commission shall publish notice thereof in the Federal Register. 
The Commission shall conclude any such investigation and make its determination 
under this section at the earliest practicable time after the date of publication of 
notice of such investigation. To promote expeditious adjudication, the Commission 
shall, within 45 days after an investigation is initiated, establish a target date for its 
final determination.  
(2) During the course of each investigation under this section, the Commission shall 
consult with, and seek advice and information from, the Department of Health and 
Human Services, the Department of Justice, the Federal Trade Commission, and 
such other departments and agencies as it considers appropriate.  
(3) Whenever, in the course of an investigation under this section, the Commission 
has reason to believe, based on information before it, that a matter, in whole or in 
part, may come within the purview of part II of subtitle IV of this chapter, it shall 
promptly notify the Secretary of Commerce so that such action may be taken as is 
otherwise authorized by such part II. If the Commission has reason to believe that 
the matter before it  
(A) is based solely on alleged acts and effects which are within the purview of 
section 1671 or 1673 of this title, or  
(B) relates to an alleged copyright infringement with respect to which action is 
prohibited by section 1008 of title 17, the Commission shall terminate, or not 
institute, any investigation into the matter. If the Commission has reason to 
believe the matter before it is based in part on alleged acts and effects which are 
within the purview of section 1671 or 1673 of this title, and in part on alleged 
acts and effects which may, independently from or in conjunction with those 
within the purview of such section, establish a basis for relief under this section, 
then it may institute or continue an investigation into the matter. If the 
Commission notifies the Secretary or the administering authority (as defined in 
section 1677 (1) of this title) with respect to a matter under this paragraph, the 
Commission may suspend its investigation during the time the matter is before 
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the Secretary or administering authority for final decision. Any final decision by 
the administering authority under section 1671 or 1673 of this title with respect 
to the matter within such section 1671 or 1673 of this title of which the 
Commission has notified the Secretary or administering authority shall be 
conclusive upon the Commission with respect to the issue of less-than-fair-value 
sales or subsidization and the matters necessary for such decision.  
 
(c) Determinations; review  
The Commission shall determine, with respect to each investigation conducted by it 
under this section, whether or not there is a violation of this section, except that the 
Commission may, by issuing a consent order or on the basis of an agreement between 
the private parties to the investigation, including an agreement to present the matter for 
arbitration, terminate any such investigation, in whole or in part, without making such a 
determination. Each determination under subsection (d) or (e) of this section shall be 
made on the record after notice and opportunity for a hearing in conformity with the 
provisions of subchapter II of chapter 5 of title 5. All legal and equitable defenses may 
be presented in all cases. A respondent may raise any counterclaim in a manner 
prescribed by the Commission. Immediately after a counterclaim is received by the 
Commission, the respondent raising such counterclaim shall file a notice of removal 
with a United States district court in which venue for any of the counterclaims raised by 
the party would exist under section 1391 of title 28. Any counterclaim raised pursuant 
to this section shall relate back to the date of the original complaint in the proceeding 
before the Commission. Action on such counterclaim shall not delay or affect the 
proceeding under this section, including the legal and equitable defenses that may be 
raised under this subsection. Any person adversely affected by a final determination of 
the Commission under subsection (d), (e), (f), or (g) of this section may appeal such 
determination, within 60 days after the determination becomes final, to the United 
States Court of Appeals for the Federal Circuit for review in accordance with chapter 7 
of title 5. Notwithstanding the foregoing provisions of this subsection, Commission 
determinations under subsections (d), (e), (f), and (g) of this section with respect to its 
findings on the public health and welfare, competitive conditions in the United States 
economy, the production of like or directly competitive articles in the United States, and 
United States consumers, the amount and nature of bond, or the appropriate remedy 
shall be reviewable in accordance with section 706 of title 5. Determinations by the 
Commission under subsections (e), (f), and (j) of this section with respect to forfeiture 
of bonds and under subsection (h) of this section with respect to the imposition of 
sanctions for abuse of discovery or abuse of process shall also be reviewable in 
accordance with section 706 of title 5.  
 
(d) Exclusion of articles from entry  
(1) If the Commission determines, as a result of an investigation under this section, 
that there is a violation of this section, it shall direct that the articles concerned, 
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imported by any person violating the provision of this section, be excluded from 
entry into the United States, unless, after considering the effect of such exclusion 
upon the public health and welfare, competitive conditions in the United States 
economy, the production of like or directly competitive articles in the United States, 
and United States consumers, it finds that such articles should not be excluded from 
entry. The Commission shall notify the Secretary of the Treasury of its action under 
this subsection directing such exclusion from entry, and upon receipt of such notice, 
the Secretary shall, through the proper officers, refuse such entry.  
(2) The authority of the Commission to order an exclusion from entry of articles 
shall be limited to persons determined by the Commission to be violating this 
section unless the Commission determines that—  
(A) a general exclusion from entry of articles is necessary to prevent 
circumvention of an exclusion order limited to products of named persons; or  
(B) there is a pattern of violation of this section and it is difficult to identify the 
source of infringing products.  
 
(e) Exclusion of articles from entry during investigation except under bond; procedures 
applicable; preliminary relief  
(1) If, during the course of an investigation under this section, the Commission 
determines that there is reason to believe that there is a violation of this section, it 
may direct that the articles concerned, imported by any person with respect to whom 
there is reason to believe that such person is violating this section, be excluded from 
entry into the United States, unless, after considering the effect of such exclusion 
upon the public health and welfare, competitive conditions in the United States 
economy, the production of like or directly competitive articles in the United States, 
and United States consumers, it finds that such articles should not be excluded from 
entry. The Commission shall notify the Secretary of the Treasury of its action under 
this subsection directing such exclusion from entry, and upon receipt of such notice, 
the Secretary shall, through the proper officers, refuse such entry, except that such 
articles shall be entitled to entry under bond prescribed by the Secretary in an 
amount determined by the Commission to be sufficient to protect the complainant 
from any injury. If the Commission later determines that the respondent has violated 
the provisions of this section, the bond may be forfeited to the complainant.  
(2) A complainant may petition the Commission for the issuance of an order under 
this subsection. The Commission shall make a determination with regard to such 
petition by no later than the 90th day after the date on which the Commission’s 
notice of investigation is published in the Federal Register. The Commission may 
extend the 90-day period for an additional 60 days in a case it designates as a more 
complicated case. The Commission shall publish in the Federal Register its reasons 
why it designated the case as being more complicated. The Commission may 
require the complainant to post a bond as a prerequisite to the issuance of an order 
under this subsection. If the Commission later determines that the respondent has 
APPENDIX 13(5/9) 
not violated the provisions of this section, the bond may be forfeited to the 
respondent.  
(3) The Commission may grant preliminary relief under this subsection or 
subsection (f) of this section to the same extent as preliminary injunctions and 
temporary restraining orders may be granted under the Federal Rules of Civil 
Procedure.  
(4) The Commission shall prescribe the terms and conditions under which bonds 
may be forfeited under paragraphs (1) and (2).  
 
(f) Cease and desist orders; civil penalty for violation of orders  
(1) In addition to, or in lieu of, taking action under subsection (d) or (e) of this 
section, the Commission may issue and cause to be served on any person violating 
this section, or believed to be violating this section, as the case may be, an order 
directing such person to cease and desist from engaging in the unfair methods or 
acts involved, unless after considering the effect of such order upon the public 
health and welfare, competitive conditions in the United States economy, the 
production of like or directly competitive articles in the United States, and United 
States consumers, it finds that such order should not be issued. The Commission 
may at any time, upon such notice and in such manner as it deems proper, modify or 
revoke any such order, and, in the case of a revocation, may take action under 
subsection (d) or (e) of this section, as the case may be. If a temporary cease and 
desist order is issued in addition to, or in lieu of, an exclusion order under 
subsection (e) of this section, the Commission may require the complainant to post a 
bond, in an amount determined by the Commission to be sufficient to protect the 
respondent from any injury, as a prerequisite to the issuance of an order under this 
subsection. If the Commission later determines that the respondent has not violated 
the provisions of this section, the bond may be forfeited to the respondent. The 
Commission shall prescribe the terms and conditions under which the bonds may be 
forfeited under this paragraph.  
(2) Any person who violates an order issued by the Commission under paragraph 
(1) after it has become final shall forfeit and pay to the United States a civil penalty 
for each day on which an importation of articles, or their sale, occurs in violation of 
the order of not more than the greater of $100,000 or twice the domestic value of the 
articles entered or sold on such day in violation of the order. Such penalty shall 
accrue to the United States and may be recovered for the United States in a civil 
action brought by the Commission in the Federal District Court for the District of 
Columbia or for the district in which the violation occurs. In such actions, the 
United States district courts may issue mandatory injunctions incorporating the 
relief sought by the Commission as they deem appropriate in the enforcement of 
such final orders of the Commission.  
 
(g) Exclusion from entry or cease and desist order; conditions and procedures applicable  
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(1) If—  
(A) a complaint is filed against a person under this section;  
(B) the complaint and a notice of investigation are served on the person;  
(C) the person fails to respond to the complaint and notice or otherwise fails to 
appear to answer the complaint and notice;  
(D) the person fails to show good cause why the person should not be found in 
default; and  
(E) the complainant seeks relief limited solely to that person;  
the Commission shall presume the facts alleged in the complaint to be true and 
shall, upon request, issue an exclusion from entry or a cease and desist order, or 
both, limited to that person unless, after considering the effect of such exclusion 
or order upon the public health and welfare, competitive conditions in the 
United States economy, the production of like or directly competitive articles in 
the United States, and United States consumers, the Commission finds that such 
exclusion or order should not be issued.  
(2) In addition to the authority of the Commission to issue a general exclusion from 
entry of articles when a respondent appears to contest an investigation concerning a 
violation of the provisions of this section, a general exclusion from entry of articles, 
regardless of the source or importer of the articles, may be issued if—  
(A) no person appears to contest an investigation concerning a violation of the 
provisions of this section,  
(B) such a violation is established by substantial, reliable, and probative 
evidence, and  
(C) the requirements of subsection (d)(2) of this section are met.  
 
(h) Sanctions for abuse of discovery and abuse of process  
The Commission may by rule prescribe sanctions for abuse of discovery and abuse of 
process to the extent authorized by Rule 11 and Rule 37 of the Federal Rules of Civil 
Procedure.  
 
(i) Forfeiture  
(1) In addition to taking action under subsection (d) of this section, the Commission 
may issue an order providing that any article imported in violation of the provisions 
of this section be seized and forfeited to the United States if—  
(A) the owner, importer, or consignee of the article previously attempted to 
import the article into the United States;  
(B) the article was previously denied entry into the United States by reason of 
an order issued under subsection (d) of this section; and  
(C) upon such previous denial of entry, the Secretary of the Treasury provided 
the owner, importer, or consignee of the article written notice of—  
(i) such order, and  
APPENDIX 13(7/9) 
(ii) the seizure and forfeiture that would result from any further attempt to 
import the article into the United States.  
(2) The Commission shall notify the Secretary of the Treasury of any order issued 
under this subsection and, upon receipt of such notice, the Secretary of the Treasury 
shall enforce such order in accordance with the provisions of this section.  
(3) Upon the attempted entry of articles subject to an order issued under this 
subsection, the Secretary of the Treasury shall immediately notify all ports of entry 
of the attempted importation and shall identify the persons notified under paragraph 
(1)(C).  
(4) The Secretary of the Treasury shall provide—  
(A) the written notice described in paragraph (1)(C) to the owner, importer, or 
consignee of any article that is denied entry into the United States by reason of 
an order issued under subsection (d) of this section; and  
(B) a copy of such written notice to the Commission.  
 
(j) Referral to President  
(1) If the Commission determines that there is a violation of this section, or that, for 
purposes of subsection (e) of this section, there is reason to believe that there is such 
a violation, it shall—  
(A) publish such determination in the Federal Register, and  
(B) transmit to the President a copy of such determination and the action taken 
under subsection (d), (e), (f), (g), or (i) of this section, with respect thereto, 
together with the record upon which such determination is based.  
(2) If, before the close of the 60-day period beginning on the day after the day on 
which he receives a copy of such determination, the President, for policy reasons, 
disapproves such determination and notifies the Commission of his disapproval, 
then, effective on the date of such notice, such determination and the action taken 
under subsection (d), (e), (f), (g), or (i) of this section with respect thereto shall have 
no force or effect.  
(3) Subject to the provisions of paragraph (2), such determination shall, except for 
purposes of subsection (c) of this section, be effective upon publication thereof in 
the Federal Register, and the action taken under subsection (d), (e), (f), (g), or (i) of 
this section, with respect thereto shall be effective as provided in such subsections, 
except that articles directed to be excluded from entry under subsection (d) of this 
section or subject to a cease and desist order under subsection (f) of this section 
shall, until such determination becomes final, be entitled to entry under bond 
prescribed by the Secretary in an amount determined by the Commission to be 
sufficient to protect the complainant from any injury. If the determination becomes 
final, the bond may be forfeited to the complainant. The Commission shall prescribe 
the terms and conditions under which bonds may be forfeited under this paragraph.  
(4) If the President does not disapprove such determination within such 60-day 
period, or if he notifies the Commission before the close of such period that he 
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approves such determination, then, for purposes of paragraph (3) and subsection (c) 
of this section such determination shall become final on the day after the close of 
such period or the day on which the President notifies the Commission of his 
approval, as the case may be.  
 
(k) Period of effectiveness; termination of violation or modification or rescission of 
exclusion or order  
(1) Except as provided in subsections (f) and (j) of this section, any exclusion from 
entry or order under this section shall continue in effect until the Commission finds, 
and in the case of exclusion from entry notifies the Secretary of the Treasury, that 
the conditions which led to such exclusion from entry or order no longer exist.  
(2) If any person who has previously been found by the Commission to be in 
violation of this section petitions the Commission for a determination that the 
petitioner is no longer in violation of this section or for a modification or rescission 
of an exclusion from entry or order under subsection (d), (e), (f), (g), or (i) of this 
section—  
(A) the burden of proof in any proceeding before the Commission regarding 
such petition shall be on the petitioner; and  
(B) relief may be granted by the Commission with respect to such petition—  
(i) on the basis of new evidence or evidence that could not have been 
presented at the prior proceeding, or  
(ii) on grounds which would permit relief from a judgment or order under 
the Federal Rules of Civil Procedure.  
 
(l) Importation by or for United States  
Any exclusion from entry or order under subsection (d), (e), (f), (g), or (i) of this 
section, in cases based on a proceeding involving a patent, copyright, mask work, or 
design under subsection (a)(1) of this section, shall not apply to any articles imported by 
and for the use of the United States, or imported for, and to be used for, the United 
States with the authorization or consent of the Government. Whenever any article would 
have been excluded from entry or would not have been entered pursuant to the 
provisions of such subsections but for the operation of this subsection, an owner of the 
patent, copyright, mask work, or design adversely affected shall be entitled to 
reasonable and entire compensation in an action before the United States Court of 
Federal Claims pursuant to the procedures of section 1498 of title 28.  
 
(m) “United States” defined  
For purposes of this section and sections 1338 and 1340 of this title, the term “United 
States” means the customs territory of the United States as defined in general note 2 of 
the Harmonized Tariff Schedule of the United States.  
 
(n) Disclosure of confidential information  
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(1) Information submitted to the Commission or exchanged among the parties in 
connection with proceedings under this section which is properly designated as 
confidential pursuant to Commission rules may not be disclosed (except under a 
protective order issued under regulations of the Commission which authorizes 
limited disclosure of such information) to any person (other than a person described 
in paragraph (2)) without the consent of the person submitting it.  
(2) Notwithstanding the prohibition contained in paragraph (1), information referred 
to in that paragraph may be disclosed to—  
(A) an officer or employee of the Commission who is directly concerned with—  
(i) carrying out the investigation or related proceeding in connection with 
which the information is submitted,  
(ii) the administration of a bond posted pursuant to subsection (e), (f), or (j) 
of this section,  
(iii) the administration or enforcement of an exclusion order issued pursuant 
to subsection (d), (e), or (g) of this section, a cease and desist order issued 
pursuant to subsection (f) of this section, or a consent order issued pursuant 
to subsection (c) of this section,  
(iv) proceedings for the modification or rescission of a temporary or 
permanent order issued under subsection (d), (e), (f), (g), or (i) of this 
section, or a consent order issued under this section, or  
(v) maintaining the administrative record of the investigation or related 
proceeding,  
(B) an officer or employee of the United States Government who is directly 
involved in the review under subsection (j) of this section, or  
(C) an officer or employee of the United States Customs Service who is directly 
involved in administering an exclusion from entry under subsection (d), (e), or 
(g) of this section resulting from the investigation or related proceeding in 
connection with which the information is submitted.  
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Specification 
 
The specification shall contain a written description of the invention, and of the manner 
and process of making and using it, in such full, clear, concise, and exact terms as to 
enable any person skilled in the art to which it pertains, or with which it is most nearly 
connected, to make and use the same, and shall set forth the best mode contemplated by 
the inventor of carrying out his invention.  
 
The specification shall conclude with one or more claims particularly pointing out and 
distinctly claiming the subject matter which the applicant regards as his invention.  
A claim may be written in independent or, if the nature of the case admits, in dependent 
or multiple dependent form.  
 
Subject to the following paragraph, a claim in dependent form shall contain a reference 
to a claim previously set forth and then specify a further limitation of the subject matter 
claimed. A claim in dependent form shall be construed to incorporate by reference all 
the limitations of the claim to which it refers.  
 
A claim in multiple dependent form shall contain a reference, in the alternative only, to 
more than one claim previously set forth and then specify a further limitation of the 
subject matter claimed. A multiple dependent claim shall not serve as a basis for any 
other multiple dependent claim. A multiple dependent claim shall be construed to 
incorporate by reference all the limitations of the particular claim in relation to which it 
is being considered.  
 
An element in a claim for a combination may be expressed as a means or step for 
performing a specified function without the recital of structure, material, or acts in 
support thereof, and such claim shall be construed to cover the corresponding structure, 
material, or acts described in the specification and equivalents thereof.  
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Reissue of defective patents 
 
Whenever any patent is, through error without any deceptive intention, deemed wholly 
or partly inoperative or invalid, by reason of a defective specification or drawing, or by 
reason of the patentee claiming more or less than he had a right to claim in the patent, 
the Director shall, on the surrender of such patent and the payment of the fee required 
by law, reissue the patent for the invention disclosed in the original patent, and in 
accordance with a new and amended application, for the unexpired part of the term of 
the original patent. No new matter shall be introduced into the application for reissue.  
 
The Director may issue several reissued patents for distinct and separate parts of the 
thing patented, upon demand of the applicant, and upon payment of the required fee for 
a reissue for each of such reissued patents.  
 
The provisions of this title relating to applications for patent shall be applicable to 
applications for reissue of a patent, except that application for reissue may be made and 
sworn to by the assignee of the entire interest if the application does not seek to enlarge 
the scope of the claims of the original patent.  
 
No reissued patent shall be granted enlarging the scope of the claims of the original 
patent unless applied for within two years from the grant of the original patent.  
 
  
 
APPENDIX 16(1/2) 
APPENDIX 16: USC Sections 1-7 of title 15: Sherman Antitrust Act  
 
 
Section 1. Trusts, etc., in restraint of trade illegal; penalty 
Every contract, combination in the form of trust or otherwise, or conspiracy, in restraint 
of trade or commerce among the several States, or with foreign nations, is declared to be 
illegal. Every person who shall make any contract or engage in any combination or 
conspiracy hereby declared to be illegal shall be deemed guilty of a felony, and, on 
conviction thereof, shall be punished by fine not exceeding $10,000,000 if a 
corporation, or, if any other person, $350,000, or by imprisonment not exceeding three 
years, or by both said punishments, in the discretion of the court. 
Section 2. Monopolizing trade a felony; penalty 
Every person who shall monopolize, or attempt to monopolize, or combine or conspire 
with any other person or persons, to monopolize any part of the trade or commerce 
among the several States, or with foreign nations, shall be deemed guilty of a felony, 
and, on conviction thereof, shall be punished by fine not exceeding $10,000,000 if a 
corporation, or, if any other person, $350,000, or by imprisonment not exceeding three 
years, or by both said punishments, in the discretion of the court. 
Section 3. Trusts in Territories or District of Columbia illegal; combination a 
felony 
Every contract, combination in form of trust or otherwise, or conspiracy, in restraint of 
trade or commerce in any Territory of the United States or of the District of Columbia, 
or in restraint of trade or commerce between any such Territory and another, or between 
any such Territory or Territories and any State or States or the District of Columbia, or 
with foreign nations, or between the District of Columbia and any State or States or 
foreign nations, is declared illegal. Every person who shall make any such contract or 
engage in any such combination or conspiracy, shall be deemed guilty of a felony, and, 
on conviction thereof, shall be punished by fine not exceeding $10,000,000 if a 
corporation, or, if any other person, $350,000, or by imprisonment not exceeding three 
years, or both said punishments, in the discretion of the court. 
Section 4. Jurisdiction of courts; duty of United States attorneys; procedure 
The several district courts of the United States are invested with jurisdiction to prevent 
and restrain violations of sections 1 to 7 of this title; and it shall be the duty of the 
several United States attorneys, in their respective districts, under the direction of the 
Attorney General, to institute proceedings in equity to prevent and restrain such 
violations. Such proceedings may be by way of petition setting forth the case and 
praying that such violation shall be enjoined or otherwise prohibited. When the parties 
complained of shall have been duly notified of such petition the court shall proceed, as 
soon as may be, to the hearing and determination of the case; and pending such petition 
and before final decree, the court may at any time make such temporary restraining 
order or prohibition as shall be deemed just in the premises.  
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Section 5. Bringing in additional parties 
Whenever it shall appear to the court before which any proceeding under section 4 of 
this title may be pending, that the ends of justice require that other parties should be 
brought before the court, the court may cause them to be summoned, whether they 
reside in the district in which the court is held or not; and subpoenas to that end may be 
served in any district by the marshal thereof. 
Section 6. Forfeiture of property in transit 
Any property owned under any contract or by any combination, or pursuant to any 
conspiracy (and being the subject thereof) mentioned in section 1 of this title, and being 
in the course of transportation from one State to another, or to a foreign country, shall 
be forfeited to the United States, and may be seized and condemned by like proceedings 
as those provided by law for the forfeiture, seizure, and condemnation of property 
imported into the United States contrary to law. 
Section 6a. Conduct involving trade or commerce with foreign nations  
Sections 1 to 7 of this title shall not apply to conduct involving trade or commerce 
(other than import trade or import commerce) with foreign nations unless -  
• (1) such conduct has a direct, substantial, and reasonably foreseeable effect -  
o (A) on trade or commerce which is not trade or commerce with foreign 
nations, or on import trade or import commerce with foreign nations; or  
o (B) on export trade or export commerce with foreign nations, of a person 
engaged in such trade or commerce in the United States; and  
• (2) such effect gives rise to a claim under the provisions of sections 1 to 7 of this 
title, other than this section.  
If sections 1 to 7 of this title apply to such conduct only because of the operation of 
paragraph (1)(B), then sections 1 to 7 of this title shall apply to such conduct only for 
injury to export business in the United States. 
Section 7. ''Person'' or ''persons'' defined 
The word ''person'', or ''persons'', wherever used in sections 1 to 7 of this title shall be 
deemed to include corporations and associations existing under or authorized by the 
laws of either the United States, the laws of any of the Territories, the laws of any State, 
or the laws of any foreign country. 
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APPENDIX 17: TRIPS Agreement: Article 8 
 
 
Article 8, Principles 
 
1. Members may, in formulating or amending their laws and regulations, adopt measures 
necessary to protect public health and nutrition, and to promote the public interest in 
sectors of vital importance to their socio-economic and technological development, 
provided that such measures are consistent with the provisions of this Agreement. 
 
2. Appropriate measures, provided that they are consistent with the provisions of this 
Agreement, may be needed to prevent the abuse of intellectual property rights by right 
holders or the resort to practices which unreasonably restrain trade or adversely affect the 
international transfer of technology. 
 
 
